id	l1	l2	f	f1	f2	N
0	current	knowledge	1.000000	1.000000	1.000000	12878
1	cyclin-like	dna	1.000000	3.000000	19.000000	12878
2	fp	promoter	1.000000	1.000000	63.000000	12878
3	gp350/	220	1.000000	1.000000	1.000000	12878
6	physiological	conditions	1.000000	1.000000	2.000000	12878
7	potent	inhibitors	1.000000	4.000000	11.000000	12878
8	ric	gire	2.000000	5.000000	4.000000	12878
9	second	e2f-i	1.000000	5.000000	2.000000	12878
10	serine-threonine	phosphatase	1.000000	1.000000	6.000000	12878
11	transcriptional	regulation	3.000000	23.000000	15.000000	12878
15	cell	division	1.000000	69.000000	1.000000	12878
17	human	nk	3.000000	72.000000	4.000000	12878
19	interleukin	responsiveness	1.000000	7.000000	8.000000	12878
20	linear	ebv	1.000000	2.000000	7.000000	12878
24	b-independent	hiv	1.000000	1.000000	8.000000	12878
25	cell-specific	histone	1.000000	5.000000	1.000000	12878
27	expression	vectors	1.000000	87.000000	1.000000	12878
30	induction	levels	1.000000	42.000000	27.000000	12878
33	relative	ratio	1.000000	3.000000	2.000000	12878
34	several	hours	1.000000	11.000000	1.000000	12878
35	src	homology	2.000000	2.000000	4.000000	12878
36	target	quantity	1.000000	10.000000	1.000000	12878
37	thp-1	cells	2.000000	3.000000	152.000000	12878
38	tumour	necrosis	1.000000	1.000000	4.000000	12878
39	virus	i	1.000000	9.000000	24.000000	12878
40	additional	mechanism	1.000000	5.000000	9.000000	12878
48	initiation	site	2.000000	3.000000	39.000000	12878
49	jak-stat	pathway	2.000000	3.000000	13.000000	12878
52	molecular	basis	1.000000	6.000000	1.000000	12878
55	necrosis	factor	3.000000	4.000000	45.000000	12878
57	protein-protein	interaction	1.000000	1.000000	4.000000	12878
60	single	t	1.000000	7.000000	76.000000	12878
62	staphylococcal	enterotoxin	1.000000	1.000000	1.000000	12878
64	estrogen	receptor	4.000000	6.000000	44.000000	12878
65	a-induced	i	1.000000	1.000000	24.000000	12878
66	autoregulatory	mechanism	1.000000	1.000000	9.000000	12878
67	beta	message	2.000000	4.000000	3.000000	12878
68	binding	capacity	2.000000	39.000000	3.000000	12878
69	core	sequences	1.000000	2.000000	8.000000	12878
70	distinct	changes	1.000000	17.000000	3.000000	12878
71	er	expressions	1.000000	5.000000	1.000000	12878
72	functional	assays	1.000000	9.000000	11.000000	12878
73	hepor	transcription	1.000000	6.000000	80.000000	12878
75	il-2-inducible	component	1.000000	3.000000	3.000000	12878
77	new	insights	1.000000	7.000000	1.000000	12878
79	ras-raf-1-map	kinase	1.000000	1.000000	35.000000	12878
80	signal	transduction	2.000000	8.000000	2.000000	12878
82	top	tamarin	1.000000	1.000000	1.000000	12878
83	transcription	complex	1.000000	80.000000	17.000000	12878
87	differential	sensitivity	1.000000	7.000000	2.000000	12878
88	e1a-immortalized	cells	1.000000	1.000000	152.000000	12878
90	hcleo	element	1.000000	4.000000	16.000000	12878
93	lymphocytes	results	1.000000	14.000000	27.000000	12878
94	moderate	levels	1.000000	1.000000	27.000000	12878
95	primer	extension	2.000000	2.000000	2.000000	12878
96	recombinant	proteins	1.000000	3.000000	36.000000	12878
97	suppressor	gene	1.000000	4.000000	96.000000	12878
98	t	leukemia	1.000000	76.000000	7.000000	12878
99	various	tumor	1.000000	13.000000	10.000000	12878
101	c-fos	mrna	2.000000	17.000000	31.000000	12878
103	cytokine	profiles	1.000000	11.000000	1.000000	12878
105	endothelial	activation	5.000000	14.000000	72.000000	12878
106	fusion	transcript	1.000000	1.000000	2.000000	12878
108	human	immunodeficiency	2.000000	72.000000	3.000000	12878
109	human	nm23-h1	1.000000	72.000000	1.000000	12878
110	il-12	synergized	1.000000	4.000000	1.000000	12878
111	il-2	transcription	1.000000	26.000000	80.000000	12878
112	il-2r	beta	1.000000	8.000000	4.000000	12878
115	mnp	protein	1.000000	6.000000	59.000000	12878
117	nfat-1-mediated	transcription	1.000000	3.000000	80.000000	12878
118	nk	cells	2.000000	4.000000	152.000000	12878
121	tyrosine	phosphorylation	13.000000	28.000000	37.000000	12878
122	alpha	b1	4.000000	56.000000	4.000000	12878
124	care	unit	1.000000	1.000000	1.000000	12878
125	cis-acting	element	1.000000	4.000000	16.000000	12878
126	egr-1	transcription	1.000000	6.000000	80.000000	12878
128	first	exon	2.000000	4.000000	3.000000	12878
129	hcleo	region	1.000000	4.000000	28.000000	12878
130	identical	sensitivities	1.000000	2.000000	1.000000	12878
131	lymphoma-derived	hybridoma	1.000000	1.000000	1.000000	12878
132	monocyte	differentiation	1.000000	6.000000	25.000000	12878
133	nfat-1-linked	lac-z	1.000000	1.000000	2.000000	12878
134	protein	phosphatase	1.000000	59.000000	6.000000	12878
135	s6	kinase	1.000000	1.000000	35.000000	12878
136	scrambled	sequence	1.000000	1.000000	22.000000	12878
137	splenic	erythroblasts	1.000000	1.000000	2.000000	12878
138	transcriptional	activity	3.000000	23.000000	46.000000	12878
139	antigen	expression	1.000000	8.000000	87.000000	12878
141	carg	motif	1.000000	1.000000	7.000000	12878
145	cytolytic	susceptibility	2.000000	3.000000	5.000000	12878
146	deletion	analysis	1.000000	4.000000	12.000000	12878
148	eber-1	loci	1.000000	1.000000	1.000000	12878
149	erythroid	cells	5.000000	24.000000	152.000000	12878
150	factor	gata-1	1.000000	45.000000	8.000000	12878
151	il-12-induced	gene	1.000000	1.000000	96.000000	12878
152	inducible	complex	1.000000	7.000000	17.000000	12878
153	intercellular	adhesion	2.000000	2.000000	14.000000	12878
155	major	transcription	1.000000	9.000000	80.000000	12878
156	nm23	protein	1.000000	10.000000	59.000000	12878
158	p95vav-induced	nfat	1.000000	1.000000	6.000000	12878
160	prolactin-induced	transcription	1.000000	1.000000	80.000000	12878
162	tal1	dna	1.000000	6.000000	19.000000	12878
163	transactivator	e2f-i	1.000000	4.000000	2.000000	12878
165	u937	cells	7.000000	13.000000	152.000000	12878
166	cells-binding	factor	1.000000	1.000000	45.000000	12878
168	alpha	phosphorylation	3.000000	56.000000	37.000000	12878
169	chromatin-dependent	manner	2.000000	2.000000	7.000000	12878
171	cooperative	effect	1.000000	1.000000	21.000000	12878
172	er	gene	1.000000	6.000000	96.000000	12878
173	erythroid-specific	gata-1	1.000000	2.000000	8.000000	12878
176	independent	sites	1.000000	3.000000	15.000000	12878
177	major	histocompatibility	3.000000	9.000000	3.000000	12878
178	nfat-1-mediated	beta-galactosidase	1.000000	3.000000	2.000000	12878
179	platelet	aggregation	1.000000	3.000000	1.000000	12878
180	protein	binds	1.000000	59.000000	2.000000	12878
181	stem	cell	1.000000	3.000000	69.000000	12878
183	tcr	activation	2.000000	16.000000	72.000000	12878
184	vd	treatment	1.000000	1.000000	10.000000	12878
185	activation	cascade	1.000000	72.000000	4.000000	12878
189	il-2	production	2.000000	24.000000	9.000000	12878
190	il-2-inducible	dna	1.000000	3.000000	19.000000	12878
194	relative	quantification	1.000000	3.000000	2.000000	12878
198	targeted	gene	1.000000	1.000000	96.000000	12878
199	acid	sequence	1.000000	3.000000	22.000000	12878
200	cell	types	7.000000	69.000000	7.000000	12878
203	functional	characterization	1.000000	9.000000	2.000000	12878
204	greater	magnitude	1.000000	1.000000	2.000000	12878
207	homology	domains	1.000000	4.000000	3.000000	12878
208	interleukin-2	gene	1.000000	3.000000	96.000000	12878
209	lymphocyte-mediated	effects	1.000000	1.000000	18.000000	12878
210	mrna	accumulation	3.000000	31.000000	4.000000	12878
211	nm23	genes	1.000000	10.000000	16.000000	12878
213	posttranscriptional	levels	1.000000	1.000000	27.000000	12878
214	susceptible	target	1.000000	1.000000	10.000000	12878
215	t	lymphocytes	5.000000	76.000000	14.000000	12878
217	-like	site	1.000000	1.000000	39.000000	12878
219	band	3	1.000000	3.000000	5.000000	12878
220	band	4.1	1.000000	3.000000	1.000000	12878
221	blastic	transformation	1.000000	1.000000	2.000000	12878
222	cd4	transcription	1.000000	7.000000	80.000000	12878
225	early	expression	1.000000	5.000000	87.000000	12878
226	enhancer	activation	2.000000	16.000000	72.000000	12878
230	important	immunoregulatory	2.000000	13.000000	2.000000	12878
231	kappa	b-alpha	5.000000	22.000000	5.000000	12878
232	low	activity	1.000000	4.000000	46.000000	12878
233	mnp	site	3.000000	6.000000	39.000000	12878
234	model	changes	1.000000	6.000000	3.000000	12878
235	monocytic	cell	1.000000	7.000000	69.000000	12878
236	secretable	cytokines	1.000000	1.000000	10.000000	12878
237	active	form	1.000000	2.000000	3.000000	12878
239	b	cells	3.000000	6.000000	152.000000	12878
240	c-rich	5	2.000000	5.000000	4.000000	12878
242	cell	v-atpase	1.000000	69.000000	3.000000	12878
243	hiv	promoter	1.000000	8.000000	63.000000	12878
244	nuclear	factors	4.000000	29.000000	23.000000	12878
246	peripheral	cd4-cd8-	1.000000	9.000000	3.000000	12878
248	present	studies	1.000000	6.000000	10.000000	12878
249	promoter	activity	13.000000	63.000000	46.000000	12878
250	protection	analyses	1.000000	1.000000	3.000000	12878
253	tumor	suppressor	2.000000	10.000000	4.000000	12878
258	distinct	elements	1.000000	17.000000	12.000000	12878
259	electrophoretic	mobilities	1.000000	5.000000	1.000000	12878
260	estrogen	predominance	1.000000	6.000000	1.000000	12878
261	factors	nf-kappa	1.000000	23.000000	44.000000	12878
262	full	maturation	1.000000	4.000000	2.000000	12878
263	gamma	ri	4.000000	11.000000	4.000000	12878
264	gene	disruption	1.000000	96.000000	2.000000	12878
265	hepor	promoter	3.000000	6.000000	63.000000	12878
266	human	udg	1.000000	72.000000	7.000000	12878
268	il-4	gene	1.000000	2.000000	96.000000	12878
270	protein	pairs	1.000000	59.000000	1.000000	12878
271	relative	formation	1.000000	3.000000	8.000000	12878
272	transcription	rate	1.000000	80.000000	7.000000	12878
276	domain	activity	1.000000	6.000000	46.000000	12878
277	extension	analysis	1.000000	2.000000	12.000000	12878
278	further	increase	2.000000	3.000000	6.000000	12878
279	heterologous	promoter	1.000000	1.000000	63.000000	12878
281	me1a1	g3ag4ag3	1.000000	1.000000	1.000000	12878
284	novel	fusion	1.000000	10.000000	1.000000	12878
285	peer	cells	1.000000	2.000000	152.000000	12878
287	replicative	genes	1.000000	2.000000	16.000000	12878
288	retinoic	acid	1.000000	1.000000	6.000000	12878
292	subunit	gene	1.000000	4.000000	96.000000	12878
293	vacuolar	h(+)-atpase	2.000000	2.000000	2.000000	12878
295	cell	activation	4.000000	69.000000	72.000000	12878
299	distinct	cytokines	1.000000	17.000000	10.000000	12878
300	distinct	epitopes	1.000000	17.000000	3.000000	12878
303	high	g	1.000000	11.000000	7.000000	12878
304	human	equivalent	1.000000	72.000000	1.000000	12878
306	identical	sequences	1.000000	2.000000	8.000000	12878
309	n-terminal	fragment	1.000000	4.000000	2.000000	12878
311	nm23	gene	3.000000	10.000000	96.000000	12878
312	phosphorylated	i	1.000000	2.000000	24.000000	12878
313	putative	guanine	1.000000	3.000000	1.000000	12878
314	receptor	interaction	1.000000	44.000000	4.000000	12878
315	receptor	motifs	1.000000	44.000000	4.000000	12878
316	t	lymphocyte	1.000000	76.000000	6.000000	12878
317	vascular	cell	2.000000	2.000000	69.000000	12878
318	bacterial	lipopolysaccharide	1.000000	2.000000	2.000000	12878
319	basal	activity	1.000000	4.000000	46.000000	12878
320	calcium	stimulation	1.000000	13.000000	21.000000	12878
321	cdna	clone	1.000000	3.000000	1.000000	12878
322	cell	lines	4.000000	69.000000	13.000000	12878
323	cycle	control	1.000000	2.000000	14.000000	12878
325	delayed	administration	1.000000	1.000000	3.000000	12878
327	factor	promoter	1.000000	45.000000	63.000000	12878
328	hcmv	dna	1.000000	4.000000	19.000000	12878
330	human	cleo	1.000000	72.000000	3.000000	12878
331	inducible	protein	1.000000	7.000000	59.000000	12878
332	jurkat	t	4.000000	13.000000	76.000000	12878
333	lymphocyte	syndrome	1.000000	6.000000	2.000000	12878
335	murine	t	1.000000	3.000000	76.000000	12878
336	response	element	1.000000	22.000000	16.000000	12878
337	strand	competition	1.000000	1.000000	2.000000	12878
339	vcam-1	gene	1.000000	12.000000	96.000000	12878
341	additional	expression	1.000000	5.000000	87.000000	12878
342	alpha	a1	3.000000	56.000000	3.000000	12878
343	b	cell	1.000000	6.000000	69.000000	12878
344	b1/	alpha	1.000000	1.000000	56.000000	12878
345	causal	relationship	1.000000	1.000000	3.000000	12878
346	cd19	mrna	1.000000	4.000000	31.000000	12878
347	different	nf-kappa	1.000000	16.000000	44.000000	12878
348	efficient	c-fos	1.000000	1.000000	17.000000	12878
351	further	studies	1.000000	3.000000	10.000000	12878
355	infected	thymocytes	3.000000	4.000000	8.000000	12878
357	leukocyte	adhesion	1.000000	1.000000	14.000000	12878
359	mrl-ipr/	ipr	1.000000	1.000000	2.000000	12878
360	nuclear	factor	5.000000	29.000000	45.000000	12878
361	nur77	family	2.000000	3.000000	11.000000	12878
362	p95vav	involvement	1.000000	12.000000	3.000000	12878
363	possible	role	1.000000	4.000000	15.000000	12878
364	promoter	domain	2.000000	63.000000	6.000000	12878
367	terminal	events	1.000000	1.000000	4.000000	12878
368	78-nucleotide	segment	1.000000	1.000000	2.000000	12878
369	binding	elements	1.000000	39.000000	12.000000	12878
374	ciita	inducibility	1.000000	6.000000	4.000000	12878
375	dose-dependent	inhibition	1.000000	1.000000	10.000000	12878
377	far-upstream	alpha-globin	1.000000	1.000000	10.000000	12878
383	leukemic	cells	1.000000	1.000000	152.000000	12878
384	lps	responses	1.000000	12.000000	2.000000	12878
385	ltr-driven	luciferase	1.000000	1.000000	2.000000	12878
388	regulatory	region	1.000000	7.000000	28.000000	12878
389	response-1	gene	2.000000	2.000000	96.000000	12878
390	squamous	cell	1.000000	1.000000	69.000000	12878
395	binding	proteins	7.000000	39.000000	36.000000	12878
396	cellular	stimuli	1.000000	8.000000	2.000000	12878
399	distinct	stages	1.000000	17.000000	2.000000	12878
400	enhanced	gr	1.000000	4.000000	4.000000	12878
402	gel	shift	1.000000	3.000000	8.000000	12878
406	il-2	induction	1.000000	24.000000	42.000000	12878
407	lymphocyte	precursors	1.000000	6.000000	1.000000	12878
408	monocyte	specificity	1.000000	6.000000	2.000000	12878
409	multiple	signals	1.000000	7.000000	17.000000	12878
410	ndp	kinase	1.000000	1.000000	35.000000	12878
411	nm23/	ndp	1.000000	1.000000	9.000000	12878
415	steroid	receptor	1.000000	2.000000	44.000000	12878
417	transcription	start	2.000000	80.000000	4.000000	12878
419	alpha	a-gene	1.000000	56.000000	1.000000	12878
421	cyclin-like	species	1.000000	3.000000	3.000000	12878
423	cytomegalovirus	ie2	1.000000	2.000000	3.000000	12878
424	dioxin-mediated	alteration	1.000000	1.000000	1.000000	12878
427	ifn-gamma	pre-treatment	1.000000	32.000000	2.000000	12878
429	lps	addition	1.000000	12.000000	9.000000	12878
430	mixed	cytosol	2.000000	4.000000	8.000000	12878
432	myeloid	leukemia	1.000000	7.000000	7.000000	12878
434	novel	transcription	2.000000	10.000000	80.000000	12878
435	ocim1	cells	2.000000	2.000000	152.000000	12878
438	predominant	factor	1.000000	1.000000	45.000000	12878
439	promoter	reporter	1.000000	63.000000	10.000000	12878
440	protein-dna	complexes	1.000000	2.000000	6.000000	12878
445	camp-inducing	agents	1.000000	1.000000	3.000000	12878
449	-dependent	growth	1.000000	1.000000	7.000000	12878
450	activator	protein-1	1.000000	4.000000	1.000000	12878
453	dna	mobility	1.000000	19.000000	8.000000	12878
454	erythroid	gene	1.000000	24.000000	96.000000	12878
455	g1	phase	1.000000	1.000000	6.000000	12878
457	hiv	tat	2.000000	8.000000	2.000000	12878
458	ifn-gamma	production	1.000000	32.000000	9.000000	12878
459	jak2	tyrosine	2.000000	4.000000	28.000000	12878
460	ligand-induced	tyrosine	1.000000	1.000000	28.000000	12878
461	monocyte-specific	function	1.000000	1.000000	10.000000	12878
463	nk3.3	cell	1.000000	2.000000	69.000000	12878
464	promoter	fragment	1.000000	63.000000	2.000000	12878
468	surface	immunoglobulin	1.000000	10.000000	2.000000	12878
470	binding	activity	1.000000	39.000000	46.000000	12878
471	cd34+	cells	1.000000	1.000000	152.000000	12878
475	dna-binding	complex	1.000000	1.000000	17.000000	12878
478	functional	consequence	1.000000	9.000000	1.000000	12878
479	hematopoietic	gene	1.000000	8.000000	96.000000	12878
481	novo	infection	1.000000	2.000000	13.000000	12878
482	peripheral	blood	6.000000	9.000000	9.000000	12878
483	pets	site	1.000000	1.000000	39.000000	12878
485	selective	inhibitor	1.000000	2.000000	9.000000	12878
486	steroid	receptors	1.000000	2.000000	12.000000	12878
490	b7/	lfa-3	1.000000	2.000000	4.000000	12878
491	cp/	wp	1.000000	1.000000	1.000000	12878
495	lymphocytic	cell	1.000000	1.000000	69.000000	12878
496	n-terminal	activation	1.000000	4.000000	72.000000	12878
497	northern	blot	2.000000	2.000000	2.000000	12878
498	oka	stimulation	1.000000	6.000000	21.000000	12878
500	promoter	sequences	2.000000	63.000000	8.000000	12878
501	same	time	1.000000	7.000000	2.000000	12878
502	state	levels	1.000000	2.000000	27.000000	12878
503	target	cells	3.000000	10.000000	152.000000	12878
505	bind	stat	1.000000	9.000000	13.000000	12878
506	binding	motif	1.000000	39.000000	7.000000	12878
507	bzlf-1	locus	1.000000	1.000000	3.000000	12878
513	immunoregulatory	cytokine	1.000000	2.000000	11.000000	12878
514	lfa-3	costimulation	2.000000	4.000000	5.000000	12878
515	lipoxygenase	metabolites	1.000000	1.000000	1.000000	12878
516	map	kinase	1.000000	2.000000	35.000000	12878
517	marked	increase	1.000000	3.000000	6.000000	12878
518	molecular	mechanisms	1.000000	6.000000	10.000000	12878
519	myeloid	precursor	1.000000	7.000000	1.000000	12878
520	receptor	superfamily	2.000000	44.000000	2.000000	12878
521	same	stat	1.000000	7.000000	13.000000	12878
522	shift	assay	3.000000	8.000000	6.000000	12878
526	various	promoters	1.000000	13.000000	4.000000	12878
527	ca2+	ionophore	1.000000	1.000000	7.000000	12878
529	double	transfectants	1.000000	1.000000	3.000000	12878
530	functional	promoter	1.000000	9.000000	63.000000	12878
533	htlv-1	transactivator	1.000000	1.000000	4.000000	12878
535	immunoglobulin	production	1.000000	2.000000	9.000000	12878
536	negative	regulation	2.000000	6.000000	15.000000	12878
537	non-polymorphic	regions	1.000000	1.000000	6.000000	12878
538	novel	inhibitors	1.000000	10.000000	11.000000	12878
540	protein	levels	1.000000	59.000000	27.000000	12878
542	sequence	cttgg	1.000000	22.000000	1.000000	12878
544	thp-1	differentiation	1.000000	3.000000	25.000000	12878
546	various	chains	1.000000	13.000000	1.000000	12878
548	cell	transformation	1.000000	69.000000	2.000000	12878
549	cellular	stimulus	1.000000	8.000000	1.000000	12878
550	costimulatory	signals	4.000000	7.000000	17.000000	12878
551	cytokine	pleiotropy	1.000000	11.000000	2.000000	12878
552	cytoplasmic	mrna	3.000000	6.000000	31.000000	12878
555	human	erythropoietin	1.000000	72.000000	4.000000	12878
556	i	mhc	1.000000	24.000000	7.000000	12878
557	marginal	levels	1.000000	2.000000	27.000000	12878
561	t-cell	receptor	1.000000	6.000000	44.000000	12878
562	transactivator	ciita	1.000000	4.000000	6.000000	12878
564	b2	proteins	1.000000	6.000000	36.000000	12878
568	chromosomal	translocation	1.000000	1.000000	2.000000	12878
569	cycle-dependent	transcription	1.000000	1.000000	80.000000	12878
573	il-10	treatment	1.000000	1.000000	10.000000	12878
574	il-2	gene	3.000000	24.000000	96.000000	12878
576	important	component	1.000000	13.000000	3.000000	12878
577	laboratory	employees	1.000000	1.000000	1.000000	12878
578	motif	characteristic	1.000000	7.000000	1.000000	12878
579	other	leukocyte	1.000000	9.000000	1.000000	12878
580	receptor	complex	2.000000	44.000000	17.000000	12878
581	reconstitution	conditions	1.000000	1.000000	2.000000	12878
582	replicative	gene	1.000000	2.000000	96.000000	12878
586	axis	activation	1.000000	2.000000	72.000000	12878
588	beta	subunits	1.000000	4.000000	3.000000	12878
590	brief	introduction	1.000000	1.000000	1.000000	12878
591	cd28	surface	1.000000	4.000000	10.000000	12878
592	cyclin-like	udg	1.000000	3.000000	7.000000	12878
593	gamma	activation	1.000000	11.000000	72.000000	12878
594	gene	effects	1.000000	96.000000	18.000000	12878
596	hematopoietin	receptors	1.000000	2.000000	12.000000	12878
599	human	population	1.000000	72.000000	1.000000	12878
601	interferon	gamma	1.000000	1.000000	11.000000	12878
603	ionomycin	pathway	1.000000	1.000000	13.000000	12878
604	main	difference	2.000000	3.000000	4.000000	12878
606	sequence	requirements	1.000000	22.000000	3.000000	12878
608	tal1	locus	1.000000	6.000000	3.000000	12878
611	calmodulin-regulated	kinase	1.000000	1.000000	35.000000	12878
612	canonical	dna	1.000000	1.000000	19.000000	12878
613	cell	line	17.000000	69.000000	19.000000	12878
614	class	ii-positive	1.000000	18.000000	1.000000	12878
615	control	group	1.000000	14.000000	4.000000	12878
616	costimulatory	pathway	1.000000	7.000000	13.000000	12878
617	differentiation	arrest	1.000000	25.000000	1.000000	12878
618	dna	sequence	3.000000	19.000000	22.000000	12878
621	finger	protein	2.000000	3.000000	59.000000	12878
622	human	host	1.000000	72.000000	3.000000	12878
623	il	transactivator	1.000000	4.000000	4.000000	12878
624	large	family	1.000000	4.000000	11.000000	12878
625	leukemia	virus	1.000000	7.000000	9.000000	12878
626	mhc	class	4.000000	7.000000	18.000000	12878
627	phosphatase	type	1.000000	6.000000	8.000000	12878
629	saguinus	oedipus	1.000000	1.000000	1.000000	12878
630	steady	state	1.000000	1.000000	2.000000	12878
631	tal1/	scl	1.000000	1.000000	2.000000	12878
633	vessel	wall	1.000000	1.000000	1.000000	12878
634	a1	antibodies	1.000000	1.000000	4.000000	12878
635	age	25-79	1.000000	1.000000	1.000000	12878
638	cd19	gene	3.000000	4.000000	96.000000	12878
639	cd4	promoter	1.000000	4.000000	63.000000	12878
642	gel-shift	analyses	1.000000	2.000000	3.000000	12878
644	hematopoietic	lineage	2.000000	8.000000	3.000000	12878
645	hepor	gene	1.000000	6.000000	96.000000	12878
647	jurkat	cell	1.000000	13.000000	69.000000	12878
648	myc-associated	zinc	2.000000	2.000000	2.000000	12878
649	normal	ifn-gamma	1.000000	9.000000	32.000000	12878
650	surface	receptor	2.000000	10.000000	44.000000	12878
651	tata	box	2.000000	3.000000	3.000000	12878
654	competitive	inhibitor	1.000000	1.000000	9.000000	12878
655	complex	class	1.000000	17.000000	18.000000	12878
656	costimulatory	signal	2.000000	7.000000	8.000000	12878
659	distinct	pathways	1.000000	17.000000	11.000000	12878
660	erythroid	differentiation	6.000000	24.000000	25.000000	12878
661	htlv-i-transformed	cells	1.000000	1.000000	152.000000	12878
664	il-2	responsiveness	2.000000	24.000000	8.000000	12878
665	immediate-early	genes	1.000000	1.000000	16.000000	12878
667	interleukin-5/	receptor	1.000000	1.000000	44.000000	12878
672	vcam-1	promoter	1.000000	12.000000	63.000000	12878
673	west	africa	1.000000	1.000000	1.000000	12878
677	costimulated	il-2	1.000000	2.000000	26.000000	12878
680	enhanced	c-fos	1.000000	4.000000	17.000000	12878
681	factors	bind	1.000000	23.000000	9.000000	12878
682	fluorescein-labeled	amplicon	1.000000	1.000000	2.000000	12878
684	guanine	nucleotide	1.000000	1.000000	2.000000	12878
686	kinase	jak2	1.000000	35.000000	2.000000	12878
687	nk	cells	1.000000	2.000000	152.000000	12878
688	novo	ebv	1.000000	2.000000	7.000000	12878
690	proteins	stat3	1.000000	36.000000	4.000000	12878
691	responsive	element	1.000000	3.000000	16.000000	12878
692	significant	amounts	1.000000	8.000000	4.000000	12878
693	tata-less	promoter	1.000000	1.000000	63.000000	12878
694	various	fc	1.000000	13.000000	11.000000	12878
699	dose-related	increase	1.000000	1.000000	6.000000	12878
700	enzyme	uracil-dna	1.000000	5.000000	2.000000	12878
703	hematopoietin	receptor	1.000000	2.000000	44.000000	12878
707	molecular	changes	1.000000	6.000000	3.000000	12878
711	phospholipase	a2	1.000000	1.000000	1.000000	12878
712	promoter	function	1.000000	63.000000	10.000000	12878
714	susceptibility	gene	1.000000	5.000000	96.000000	12878
717	unlabeled	amplicon	1.000000	1.000000	2.000000	12878
723	mixed	lymphocyte	1.000000	4.000000	6.000000	12878
724	regulatory	pathways	1.000000	7.000000	11.000000	12878
725	related	region	1.000000	1.000000	28.000000	12878
726	transcriptional	level	1.000000	23.000000	9.000000	12878
727	transcriptional	means	1.000000	23.000000	1.000000	12878
729	2a-sensitive	sites	1.000000	1.000000	15.000000	12878
731	activation	sequence	2.000000	72.000000	22.000000	12878
733	alpha/	gos19	1.000000	1.000000	3.000000	12878
734	augments	pma-	1.000000	1.000000	1.000000	12878
735	b95-8	cytosol	2.000000	4.000000	8.000000	12878
736	beta-galactosidase	mrna	1.000000	2.000000	31.000000	12878
738	de	novo	2.000000	2.000000	2.000000	12878
740	enhancer	regions	1.000000	16.000000	6.000000	12878
741	friend	virus	1.000000	2.000000	9.000000	12878
742	gel-shift	analysis	1.000000	2.000000	12.000000	12878
743	gm-csf	element	1.000000	26.000000	16.000000	12878
744	gm-csf	expression	1.000000	26.000000	87.000000	12878
746	helper	cells	1.000000	1.000000	152.000000	12878
748	interleukin-2	control	1.000000	3.000000	14.000000	12878
750	mass	action	1.000000	1.000000	4.000000	12878
751	phorbol	ester	1.000000	2.000000	1.000000	12878
752	protein	synthesis	1.000000	59.000000	1.000000	12878
753	ribonuclease	protection	1.000000	1.000000	1.000000	12878
754	saphenous	vein	1.000000	1.000000	2.000000	12878
755	tinur	gene	1.000000	4.000000	96.000000	12878
756	uracil-dna	glycosylase	2.000000	2.000000	2.000000	12878
760	alpha	b2	5.000000	56.000000	6.000000	12878
761	alpha	subunit	1.000000	56.000000	4.000000	12878
762	different	combinations	1.000000	16.000000	1.000000	12878
770	il-2	expression	1.000000	26.000000	87.000000	12878
771	lps	stimulation	2.000000	12.000000	21.000000	12878
772	lyn	tyrosine	1.000000	3.000000	28.000000	12878
774	myeloid	leukemias	1.000000	7.000000	1.000000	12878
776	precise	role	1.000000	1.000000	15.000000	12878
777	primary	regulator	1.000000	3.000000	2.000000	12878
778	protein	kinase	4.000000	59.000000	35.000000	12878
780	sequence	similarity	2.000000	22.000000	3.000000	12878
781	site-binding	protein	1.000000	1.000000	59.000000	12878
782	stat1	alpha	4.000000	6.000000	56.000000	12878
784	ag	receptor	1.000000	1.000000	44.000000	12878
785	anti-ig	induction	2.000000	3.000000	42.000000	12878
786	cell	ag	1.000000	69.000000	1.000000	12878
787	chinese	hamster	1.000000	1.000000	1.000000	12878
793	multiple	ap2	1.000000	7.000000	1.000000	12878
794	reproductive	target	1.000000	1.000000	10.000000	12878
797	t	cell	17.000000	76.000000	69.000000	12878
799	alpha	protein	1.000000	56.000000	59.000000	12878
800	amino	acid	2.000000	3.000000	6.000000	12878
802	calcium	ionophore	2.000000	13.000000	7.000000	12878
803	calcium-dependent	pma	1.000000	1.000000	8.000000	12878
806	cytokine	message	1.000000	11.000000	3.000000	12878
807	dissociation	rate	1.000000	1.000000	7.000000	12878
808	distinct	effects	2.000000	17.000000	18.000000	12878
809	finger	region	1.000000	3.000000	28.000000	12878
810	gata-1	levels	2.000000	11.000000	27.000000	12878
811	gland	tissue	1.000000	1.000000	2.000000	12878
812	homology	3	1.000000	4.000000	5.000000	12878
814	immunodeficiency	virus	3.000000	3.000000	9.000000	12878
815	kinase	inhibitor	2.000000	35.000000	9.000000	12878
817	mouse	il-2r	1.000000	8.000000	8.000000	12878
819	palindromic	sequences	1.000000	1.000000	8.000000	12878
820	run-on	assays	1.000000	3.000000	11.000000	12878
821	s	phase	1.000000	1.000000	6.000000	12878
822	several	methods	1.000000	11.000000	2.000000	12878
823	skin	cancer	2.000000	3.000000	3.000000	12878
826	tumor	necrosis	3.000000	10.000000	4.000000	12878
827	type	i	1.000000	8.000000	24.000000	12878
831	second	messengers	1.000000	5.000000	1.000000	12878
832	stat3	complexes	1.000000	4.000000	6.000000	12878
834	acid	sequence	1.000000	6.000000	22.000000	12878
835	cd4	promoter	2.000000	7.000000	63.000000	12878
836	cell	lineages	1.000000	69.000000	1.000000	12878
838	cytokine	expression	1.000000	11.000000	87.000000	12878
839	enhanced	production	1.000000	4.000000	9.000000	12878
840	epor	promoter	1.000000	3.000000	63.000000	12878
841	gm-csf	mrnas	1.000000	26.000000	3.000000	12878
846	il-1	alpha	1.000000	6.000000	56.000000	12878
847	inhibitor	h-89	1.000000	9.000000	2.000000	12878
848	jurkat	cells	3.000000	13.000000	152.000000	12878
849	low	levels	1.000000	4.000000	27.000000	12878
850	mouse	interleukin-2	1.000000	8.000000	7.000000	12878
851	murine	macrophage	1.000000	3.000000	2.000000	12878
852	nf-at	transcription	1.000000	4.000000	80.000000	12878
857	polyomavirus	enhancer	1.000000	1.000000	16.000000	12878
858	sp1	site	1.000000	15.000000	39.000000	12878
859	t-cell	stimulation	1.000000	6.000000	21.000000	12878
861	transient	vs	1.000000	5.000000	1.000000	12878
864	beta-galactosidase	activity	1.000000	2.000000	46.000000	12878
866	cell	proliferation	3.000000	69.000000	6.000000	12878
867	cellular	processes	1.000000	8.000000	2.000000	12878
869	danazol	decreases	1.000000	5.000000	1.000000	12878
870	different	parts	1.000000	16.000000	1.000000	12878
872	early	event	1.000000	5.000000	1.000000	12878
876	kinase	protein	2.000000	35.000000	59.000000	12878
878	mutant-activated	ras	1.000000	1.000000	5.000000	12878
880	nucleoside	diphosphate	3.000000	3.000000	3.000000	12878
881	on-going	lps	1.000000	1.000000	12.000000	12878
882	ovulation	induction	1.000000	6.000000	42.000000	12878
884	several	criteria	1.000000	11.000000	2.000000	12878
885	sp1	functions	1.000000	15.000000	5.000000	12878
886	tnf-induced	nf-kappa	1.000000	1.000000	44.000000	12878
887	1,25-dihydroxyvitamin	d2	1.000000	1.000000	1.000000	12878
889	anti-cd4	mab	1.000000	1.000000	2.000000	12878
891	blood	lymphocytes	3.000000	9.000000	14.000000	12878
892	blot	analysis	2.000000	2.000000	12.000000	12878
894	different	research	1.000000	16.000000	1.000000	12878
899	il-2	cd28re	1.000000	24.000000	4.000000	12878
901	inhibitory	effect	1.000000	8.000000	21.000000	12878
904	negative	regulator	1.000000	6.000000	2.000000	12878
906	ras/	protein	1.000000	1.000000	59.000000	12878
908	signal	transducer	1.000000	8.000000	1.000000	12878
909	significant	difference	1.000000	8.000000	4.000000	12878
910	spastic	paraparesis	1.000000	1.000000	1.000000	12878
912	tcdd	treatment	1.000000	3.000000	10.000000	12878
914	transcriptional	control	1.000000	23.000000	14.000000	12878
915	biological	modifications	1.000000	5.000000	2.000000	12878
917	control	mechanisms	1.000000	14.000000	10.000000	12878
918	il-10-stimulated	stat	1.000000	1.000000	13.000000	12878
920	purine-rich	element	1.000000	3.000000	16.000000	12878
921	t	cells	44.000000	76.000000	152.000000	12878
923	alpha/	gos19	1.000000	1.000000	3.000000	12878
924	b-encoded	isomers	1.000000	1.000000	1.000000	12878
926	blood	t	1.000000	9.000000	76.000000	12878
928	critical	element	1.000000	6.000000	16.000000	12878
929	cytolytic	phenotypes	1.000000	3.000000	1.000000	12878
931	diphosphate	kinase	1.000000	3.000000	35.000000	12878
933	dr-nm23	mrna	1.000000	1.000000	31.000000	12878
934	erythroid	progenitor	2.000000	24.000000	2.000000	12878
935	experimental	system	1.000000	1.000000	3.000000	12878
938	ifn-gamma	induction	2.000000	32.000000	42.000000	12878
939	il-1	beta	1.000000	6.000000	4.000000	12878
940	mip1	alpha	1.000000	1.000000	56.000000	12878
941	monoclonal	antibodies	1.000000	1.000000	4.000000	12878
944	protein	tyrosine	3.000000	59.000000	28.000000	12878
945	rapid	signal-transduction	1.000000	5.000000	1.000000	12878
947	tumor	lines	2.000000	10.000000	13.000000	12878
950	activator	protein	1.000000	4.000000	59.000000	12878
952	constitutive	expression	2.000000	4.000000	87.000000	12878
953	cyclooxygenase	activity	1.000000	1.000000	46.000000	12878
955	erythrocyte	ndp	1.000000	2.000000	9.000000	12878
956	glucocorticoid	receptors	4.000000	17.000000	12.000000	12878
959	lac-z	reporter	1.000000	2.000000	10.000000	12878
960	lps-mediated	activation	1.000000	2.000000	72.000000	12878
961	lymphocyte	cell	1.000000	6.000000	69.000000	12878
962	nur77-related	transcription	1.000000	1.000000	80.000000	12878
963	orticoid	receptors	1.000000	1.000000	12.000000	12878
964	regulatory	elements	1.000000	7.000000	12.000000	12878
968	32dc13	cell	1.000000	2.000000	69.000000	12878
973	cytokine	redundancy	1.000000	11.000000	2.000000	12878
974	different	lines	1.000000	16.000000	13.000000	12878
975	duffy	blood	2.000000	4.000000	9.000000	12878
976	factor	alpha	1.000000	45.000000	56.000000	12878
978	functional	t-cell	1.000000	9.000000	6.000000	12878
980	ie2	protein	1.000000	3.000000	59.000000	12878
981	inflammatory	protein	1.000000	3.000000	59.000000	12878
983	intensive	care	1.000000	1.000000	1.000000	12878
986	patient	group	1.000000	1.000000	4.000000	12878
990	retinoblastoma	protein	1.000000	3.000000	59.000000	12878
991	septic	shock	6.000000	6.000000	6.000000	12878
993	alpha-globin	gene	3.000000	10.000000	96.000000	12878
995	biological	markers	1.000000	5.000000	5.000000	12878
997	distinct	region	1.000000	17.000000	28.000000	12878
999	essential	feature	1.000000	2.000000	3.000000	12878
1000	h(+)-atpase	b2	1.000000	2.000000	6.000000	12878
1001	large	amounts	1.000000	4.000000	4.000000	12878
1004	nm23-h2	gene	1.000000	3.000000	96.000000	12878
1005	powerful	enhancer	2.000000	2.000000	16.000000	12878
1006	tax	activation	1.000000	3.000000	72.000000	12878
1007	tumor	metastasis	1.000000	10.000000	3.000000	12878
1010	biological	effects	1.000000	5.000000	18.000000	12878
1011	cell	cycle	1.000000	69.000000	2.000000	12878
1012	chemical-induced	erythroleukemia	1.000000	1.000000	1.000000	12878
1014	e2f-mediated	transcription	1.000000	2.000000	80.000000	12878
1016	host	defence	1.000000	3.000000	1.000000	12878
1018	il-12	stimulation	1.000000	12.000000	21.000000	12878
1023	mapping	experiments	1.000000	1.000000	6.000000	12878
1026	multiple	tyrosine	1.000000	7.000000	28.000000	12878
1029	promoter	region	4.000000	63.000000	28.000000	12878
1031	protein-affinity	chromatography	1.000000	1.000000	1.000000	12878
1032	saos	2	1.000000	1.000000	8.000000	12878
1034	tal1	gene	1.000000	6.000000	96.000000	12878
1035	alpha-globin	enhancer	1.000000	10.000000	16.000000	12878
1037	control	subjects	1.000000	14.000000	2.000000	12878
1039	erythrocyte	receptor	1.000000	2.000000	44.000000	12878
1041	glucocorticoid	target	1.000000	17.000000	10.000000	12878
1043	leukemia	cells	1.000000	7.000000	152.000000	12878
1044	lineage-specific	activator	1.000000	1.000000	4.000000	12878
1045	lymphoid	cells	1.000000	4.000000	152.000000	12878
1046	microm	inhibitors	1.000000	2.000000	11.000000	12878
1047	mononuclear	leucocytes	1.000000	4.000000	1.000000	12878
1048	scatchard	analysis	1.000000	1.000000	12.000000	12878
1050	v-atpase	content	1.000000	3.000000	2.000000	12878
1051	asymmetric	cell	1.000000	1.000000	69.000000	12878
1052	biological	significance	1.000000	5.000000	1.000000	12878
1055	developmental	expression	1.000000	2.000000	87.000000	12878
1056	epithelial	cells	1.000000	1.000000	152.000000	12878
1057	epo-induced	phosphorylation	1.000000	1.000000	37.000000	12878
1058	functional	regions	1.000000	9.000000	6.000000	12878
1061	jak	phosphorylation	1.000000	4.000000	37.000000	12878
1064	lps-induced	tnf	2.000000	3.000000	14.000000	12878
1065	lymphoid	cell	3.000000	4.000000	69.000000	12878
1066	macrophage	cell	1.000000	2.000000	69.000000	12878
1068	mononuclear	leucocyte	1.000000	4.000000	1.000000	12878
1070	p	&amp;lt	1.000000	1.000000	1.000000	12878
1071	p95vav	overexpression	1.000000	12.000000	7.000000	12878
1072	protein	products	3.000000	59.000000	4.000000	12878
1073	recent	demonstration	1.000000	3.000000	1.000000	12878
1074	retinoblastoma	gene	1.000000	3.000000	96.000000	12878
1075	run-on	analysis	1.000000	3.000000	12.000000	12878
1077	type	1	2.000000	8.000000	7.000000	12878
1078	world	primates	1.000000	2.000000	1.000000	12878
1079	anti-cd28	ab	1.000000	1.000000	2.000000	12878
1082	human	granulocyte-macrophage	2.000000	72.000000	7.000000	12878
1085	inflammatory	process	1.000000	3.000000	1.000000	12878
1086	intracellular	calcium	2.000000	4.000000	13.000000	12878
1089	retarded	mobility	1.000000	1.000000	8.000000	12878
1093	%	sequence	1.000000	9.000000	22.000000	12878
1095	bp	promoter	1.000000	3.000000	63.000000	12878
1096	cell	cycle-dependent	1.000000	69.000000	1.000000	12878
1099	coat	protein	1.000000	1.000000	59.000000	12878
1102	ebv	genome	2.000000	7.000000	3.000000	12878
1103	er	associate	1.000000	6.000000	1.000000	12878
1106	il-2r	alpha	7.000000	8.000000	56.000000	12878
1107	intense	phosphorylation	1.000000	3.000000	37.000000	12878
1108	metastatic	potential	2.000000	4.000000	3.000000	12878
1109	metastatic	suppressor	2.000000	4.000000	4.000000	12878
1111	mouse	gm-csf	1.000000	8.000000	26.000000	12878
1113	sp1	protein	1.000000	15.000000	59.000000	12878
1116	udg	promoter	2.000000	7.000000	63.000000	12878
1118	b2	subunit	1.000000	6.000000	4.000000	12878
1119	binding	affinity	1.000000	39.000000	8.000000	12878
1121	cell	transcription	1.000000	69.000000	80.000000	12878
1122	critical	illness	2.000000	6.000000	2.000000	12878
1124	group	system	1.000000	4.000000	3.000000	12878
1127	reporter	plasmids	1.000000	10.000000	1.000000	12878
1129	stable	integration	1.000000	3.000000	1.000000	12878
1130	subsequent	monocyte	1.000000	4.000000	6.000000	12878
1133	activation	site	1.000000	72.000000	39.000000	12878
1134	bare	lymphocyte	1.000000	1.000000	6.000000	12878
1136	cellular	factors	1.000000	8.000000	23.000000	12878
1137	defence	response	1.000000	1.000000	22.000000	12878
1138	enhancer	binding-protein	1.000000	16.000000	1.000000	12878
1141	glycoprotein	hormone	1.000000	1.000000	1.000000	12878
1142	integrin-dependent	cell	1.000000	1.000000	69.000000	12878
1146	matrix-bound	rb	1.000000	1.000000	12.000000	12878
1148	nitric	oxide	3.000000	3.000000	3.000000	12878
1150	positive	effect	1.000000	3.000000	21.000000	12878
1151	preactivated	pbl	1.000000	1.000000	2.000000	12878
1152	primary	t	1.000000	3.000000	76.000000	12878
1153	recent	studies	1.000000	3.000000	10.000000	12878
1154	reporter	plasmid	1.000000	10.000000	1.000000	12878
1157	transfected	cos	1.000000	6.000000	1.000000	12878
1158	transfection	studies	1.000000	10.000000	10.000000	12878
1159	various	stimuli	1.000000	13.000000	2.000000	12878
1160	ah	receptor	4.000000	4.000000	44.000000	12878
1161	antigen	receptors	2.000000	8.000000	12.000000	12878
1162	continuous	presence	2.000000	2.000000	9.000000	12878
1163	estrogenic	receptors	1.000000	1.000000	12.000000	12878
1165	inhibitory	factor	1.000000	8.000000	45.000000	12878
1167	native	monocytes	1.000000	2.000000	27.000000	12878
1169	nuclear	runoff	1.000000	29.000000	1.000000	12878
1170	present	study	1.000000	6.000000	3.000000	12878
1173	transduction	pathways	1.000000	2.000000	11.000000	12878
1175	zeta	tyrosine	1.000000	1.000000	28.000000	12878
1176	-negative	b-cell	1.000000	1.000000	3.000000	12878
1177	20-bp	region	1.000000	1.000000	28.000000	12878
1178	aids	cases	1.000000	2.000000	2.000000	12878
1179	bone	marrow	1.000000	3.000000	1.000000	12878
1180	bp	hepor	1.000000	3.000000	6.000000	12878
1182	control	elements	1.000000	14.000000	12.000000	12878
1185	dna	repair	3.000000	19.000000	3.000000	12878
1186	e1a	gene	2.000000	6.000000	96.000000	12878
1190	granulocyte	differentiation	1.000000	2.000000	25.000000	12878
1193	human	stat	1.000000	72.000000	13.000000	12878
1195	key	cytokine	1.000000	1.000000	11.000000	12878
1196	lymphotropic	virus	1.000000	1.000000	9.000000	12878
1197	multifunctional	target	1.000000	1.000000	10.000000	12878
1198	nk	cell	1.000000	2.000000	69.000000	12878
1202	such	monocyte	1.000000	6.000000	6.000000	12878
1204	alpha-globin	g	2.000000	2.000000	7.000000	12878
1205	anti-ig	stimulation	1.000000	3.000000	21.000000	12878
1206	biological	models	1.000000	5.000000	1.000000	12878
1208	class	ii	14.000000	18.000000	16.000000	12878
1210	exogenous	il-2	1.000000	1.000000	26.000000	12878
1212	human	erythrocyte	1.000000	72.000000	2.000000	12878
1215	pp-2a-opposing	kinases	1.000000	1.000000	10.000000	12878
1218	artificial	promoter	1.000000	1.000000	63.000000	12878
1220	calcium	flux	1.000000	13.000000	1.000000	12878
1221	differential	effect	1.000000	7.000000	21.000000	12878
1227	ifn-gamma	activation	1.000000	32.000000	72.000000	12878
1228	mrna	levels	3.000000	31.000000	27.000000	12878
1229	mutagenesis	analyses	1.000000	1.000000	3.000000	12878
1230	myelogenous	leukemia	2.000000	2.000000	7.000000	12878
1233	protein	tbp	1.000000	59.000000	1.000000	12878
1235	ri	expression	1.000000	4.000000	87.000000	12878
1238	tcr	expression	1.000000	16.000000	87.000000	12878
1239	transfected	target	1.000000	6.000000	10.000000	12878
1242	cell-specific	patterns	1.000000	5.000000	1.000000	12878
1243	chemokine	receptor	2.000000	2.000000	44.000000	12878
1244	early	growth	2.000000	5.000000	7.000000	12878
1246	healthy	laboratory	1.000000	2.000000	1.000000	12878
1247	helical	turns	1.000000	1.000000	1.000000	12878
1248	hl	cytosol	1.000000	2.000000	8.000000	12878
1254	promoter	induction	1.000000	63.000000	42.000000	12878
1255	receptor	dna	1.000000	44.000000	19.000000	12878
1257	silent	fy@star@b	1.000000	1.000000	2.000000	12878
1258	target	tissues	3.000000	10.000000	4.000000	12878
1259	temperature-induced	down-regulation	1.000000	1.000000	3.000000	12878
1261	b7/	lfa-3triple	1.000000	2.000000	1.000000	12878
1262	binding	sites	8.000000	39.000000	15.000000	12878
1264	cell-specific	genes	2.000000	5.000000	16.000000	12878
1265	cellular	promoters	1.000000	8.000000	4.000000	12878
1267	developmental	control	1.000000	2.000000	14.000000	12878
1271	er	form	1.000000	6.000000	3.000000	12878
1272	g3ag4ag3	motif	1.000000	1.000000	7.000000	12878
1273	homology	2	1.000000	4.000000	8.000000	12878
1276	malaria	parasite	1.000000	1.000000	1.000000	12878
1277	map	kinases	1.000000	2.000000	10.000000	12878
1278	neoplastic	progression	1.000000	1.000000	2.000000	12878
1279	pebp2	alpha	3.000000	6.000000	56.000000	12878
1281	regulatory	effect	1.000000	7.000000	21.000000	12878
1282	shift	assays	4.000000	8.000000	11.000000	12878
1284	udg	expression	1.000000	7.000000	87.000000	12878
1285	viral	infection	1.000000	4.000000	13.000000	12878
1286	world	primate	1.000000	2.000000	1.000000	12878
1288	zlf-1	gene	1.000000	1.000000	96.000000	12878
1290	differential	assembly	1.000000	7.000000	1.000000	12878
1292	gm-csf	promoter-	1.000000	26.000000	1.000000	12878
1297	permeability-increasing	protein	2.000000	2.000000	59.000000	12878
1298	promoter-	luciferase	1.000000	1.000000	2.000000	12878
1300	surface	interactions	1.000000	10.000000	1.000000	12878
1301	b2	ratio	1.000000	6.000000	2.000000	12878
1302	brlf-1	locus	1.000000	1.000000	3.000000	12878
1303	cell	surface	5.000000	69.000000	10.000000	12878
1304	dna	strand	1.000000	19.000000	1.000000	12878
1305	estrogen	administration	1.000000	6.000000	3.000000	12878
1308	gene	family	1.000000	96.000000	11.000000	12878
1309	histone	h5	1.000000	1.000000	1.000000	12878
1311	latter	genes	1.000000	1.000000	16.000000	12878
1312	ligand-dependent	manner	2.000000	3.000000	7.000000	12878
1313	low-molecular-weight	chemokines	1.000000	1.000000	1.000000	12878
1314	major	coat	1.000000	9.000000	1.000000	12878
1316	marked	decrease	1.000000	3.000000	2.000000	12878
1317	minimal	cd4	1.000000	1.000000	4.000000	12878
1318	mononuclear	cells	2.000000	4.000000	152.000000	12878
1321	nf-kappa	b-independent	1.000000	44.000000	1.000000	12878
1322	protein	complexes	1.000000	59.000000	6.000000	12878
1324	same	complexes	2.000000	7.000000	6.000000	12878
1325	surface	expression	1.000000	10.000000	87.000000	12878
1326	terminal	repeat	1.000000	1.000000	1.000000	12878
1327	therapeutic	effects	1.000000	2.000000	18.000000	12878
1329	zebra	protein	1.000000	2.000000	59.000000	12878
1330	-dr	transfectants	1.000000	1.000000	3.000000	12878
1332	duffy-negative	individuals	2.000000	3.000000	2.000000	12878
1333	footprint	analysis	1.000000	1.000000	12.000000	12878
1334	histocompatibility	complex	1.000000	3.000000	17.000000	12878
1335	hypothalamic-pituitary-adrenal	axis	2.000000	2.000000	2.000000	12878
1336	ii	gene	1.000000	16.000000	96.000000	12878
1340	kinetic	studies	1.000000	1.000000	10.000000	12878
1342	level	gene	1.000000	9.000000	96.000000	12878
1343	ndp	kinase	7.000000	9.000000	35.000000	12878
1344	normal	human	2.000000	9.000000	6.000000	12878
1347	pma	stimulation	1.000000	8.000000	21.000000	12878
1348	possible	involvement	1.000000	4.000000	3.000000	12878
1351	tcr-like	signals	1.000000	1.000000	17.000000	12878
1352	transcription	factor	19.000000	80.000000	45.000000	12878
1353	adaptor	protein	1.000000	1.000000	59.000000	12878
1354	antigen	receptor	1.000000	8.000000	44.000000	12878
1356	basal	cell	1.000000	4.000000	69.000000	12878
1357	box	elements	1.000000	3.000000	12.000000	12878
1358	ciita	mrna	2.000000	6.000000	31.000000	12878
1360	distinct	actions	1.000000	17.000000	1.000000	12878
1361	dnase	i	2.000000	2.000000	24.000000	12878
1362	ebv	infection	1.000000	7.000000	13.000000	12878
1364	embryonic	stem	1.000000	1.000000	3.000000	12878
1367	fva	cells	1.000000	2.000000	152.000000	12878
1372	interleukin-2	expression	1.000000	3.000000	87.000000	12878
1373	jak-stat	pathways	1.000000	3.000000	11.000000	12878
1374	lymphocyte	line	1.000000	6.000000	19.000000	12878
1376	mip-1	alpha/	1.000000	5.000000	1.000000	12878
1378	oxygen	intermediates	1.000000	2.000000	1.000000	12878
1379	sequence	canntg	1.000000	22.000000	1.000000	12878
1381	calcium-independent	anti-cd28	1.000000	1.000000	1.000000	12878
1384	healthy	controls	1.000000	2.000000	1.000000	12878
1385	human	alpha-globin	2.000000	72.000000	10.000000	12878
1388	killer	cells	1.000000	2.000000	152.000000	12878
1390	lpr	cd4-cd8-	1.000000	1.000000	3.000000	12878
1391	negative	correlation	2.000000	6.000000	2.000000	12878
1392	nm23-h2his	protein	1.000000	1.000000	59.000000	12878
1393	ovulatory	situation	1.000000	1.000000	2.000000	12878
1395	proteasome-mediated	degradation	1.000000	1.000000	7.000000	12878
1396	same	cells	1.000000	7.000000	152.000000	12878
1397	sh2	domain	1.000000	1.000000	6.000000	12878
1398	species	specificity	1.000000	3.000000	2.000000	12878
1399	specific	members	1.000000	10.000000	2.000000	12878
1402	binding	studies	1.000000	39.000000	10.000000	12878
1403	calcium	pathways	1.000000	13.000000	11.000000	12878
1404	class	il	1.000000	18.000000	4.000000	12878
1405	erythroid	progenitors	1.000000	24.000000	1.000000	12878
1407	gene	promoter	3.000000	96.000000	63.000000	12878
1408	gr	mrna	1.000000	4.000000	31.000000	12878
1413	human	skin	3.000000	72.000000	3.000000	12878
1414	human	thymocytes	1.000000	72.000000	8.000000	12878
1417	lymphoblastic	leukemia	1.000000	1.000000	7.000000	12878
1419	nf-kappa	b/	1.000000	44.000000	1.000000	12878
1420	nm23	function	1.000000	10.000000	10.000000	12878
1422	obvious	merit	1.000000	2.000000	1.000000	12878
1423	previous	work	1.000000	1.000000	2.000000	12878
1425	role	monocytes	1.000000	15.000000	27.000000	12878
1426	shc	adaptor	1.000000	1.000000	1.000000	12878
1427	t-cell	activation	1.000000	6.000000	72.000000	12878
1428	tal1	mrna	1.000000	6.000000	31.000000	12878
1429	vitro	exposure	1.000000	10.000000	2.000000	12878
1430	anti-stat3	ab	1.000000	1.000000	2.000000	12878
1434	c-rel	proteins	1.000000	1.000000	36.000000	12878
1435	egr-1	promoter	2.000000	6.000000	63.000000	12878
1440	immune	responsiveness	2.000000	4.000000	8.000000	12878
1441	induction	systems	1.000000	42.000000	1.000000	12878
1442	monocyte-macrophage	differentiation	1.000000	1.000000	25.000000	12878
1444	type	2a	1.000000	8.000000	1.000000	12878
1445	amino	acids	1.000000	3.000000	1.000000	12878
1446	b-alpha	proteolysis	1.000000	5.000000	2.000000	12878
1447	cognate	receptor	1.000000	1.000000	44.000000	12878
1449	cytokine	messages	1.000000	11.000000	1.000000	12878
1450	cytoplasmic	domains	1.000000	6.000000	3.000000	12878
1452	dna-binding	complex	1.000000	1.000000	17.000000	12878
1453	full	activation	1.000000	4.000000	72.000000	12878
1455	granular	lymphocytes	1.000000	1.000000	14.000000	12878
1458	kinase	inhibitors	1.000000	35.000000	11.000000	12878
1460	ltr	constructs	1.000000	4.000000	3.000000	12878
1462	marked	reduction	1.000000	3.000000	3.000000	12878
1463	message	induction	2.000000	3.000000	42.000000	12878
1465	p95vav	activity	1.000000	12.000000	46.000000	12878
1466	potent	differentiation	1.000000	4.000000	25.000000	12878
1469	skin	cancers	1.000000	3.000000	1.000000	12878
1470	tcr	stimulation	1.000000	16.000000	21.000000	12878
1471	th2-type	lymphocytes	1.000000	1.000000	14.000000	12878
1473	bactericidal/	permeability-increasing	2.000000	2.000000	2.000000	12878
1474	cell	receptor	1.000000	69.000000	44.000000	12878
1475	i	footprinting	1.000000	24.000000	1.000000	12878
1476	lipopolysaccharide-induced	e-selectin	1.000000	1.000000	9.000000	12878
1479	binding-protein	2	1.000000	1.000000	8.000000	12878
1480	blood	group	2.000000	9.000000	4.000000	12878
1483	concentration-dependent	manner	1.000000	1.000000	7.000000	12878
1486	e2f	sites	1.000000	5.000000	15.000000	12878
1487	exchange	domain	1.000000	1.000000	6.000000	12878
1488	growth	factor-beta	2.000000	7.000000	2.000000	12878
1490	il-2	expression	2.000000	24.000000	87.000000	12878
1491	intact	tcr	1.000000	2.000000	16.000000	12878
1495	post-transcriptional	mechanisms	2.000000	2.000000	10.000000	12878
1497	promoter-driven	reporter	1.000000	1.000000	10.000000	12878
1498	protein	expression	1.000000	59.000000	87.000000	12878
1503	udg	gene	1.000000	7.000000	96.000000	12878
1504	zinc	finger	2.000000	2.000000	3.000000	12878
1506	core	sequence	1.000000	2.000000	22.000000	12878
1507	human	leukemia	1.000000	72.000000	7.000000	12878
1508	low	concentrations	1.000000	4.000000	5.000000	12878
1509	other	transcription	1.000000	9.000000	80.000000	12878
1512	selective	modulation	1.000000	2.000000	1.000000	12878
1514	alpha	expression	1.000000	56.000000	87.000000	12878
1515	aml1-related	transcription	1.000000	1.000000	80.000000	12878
1517	constitutive	hepor	1.000000	4.000000	6.000000	12878
1518	cos	cells	1.000000	1.000000	152.000000	12878
1520	dna	damage	1.000000	19.000000	1.000000	12878
1521	erythroid	ocim1	1.000000	24.000000	2.000000	12878
1522	gene	induction	1.000000	96.000000	42.000000	12878
1523	gene	transactivator	1.000000	96.000000	4.000000	12878
1524	hepor	expression	1.000000	6.000000	87.000000	12878
1525	homeostatic	control	1.000000	1.000000	14.000000	12878
1526	ick-1	family	1.000000	4.000000	11.000000	12878
1528	il-2	control	1.000000	24.000000	14.000000	12878
1530	normal	t	3.000000	9.000000	76.000000	12878
1532	proximal	position	1.000000	6.000000	1.000000	12878
1534	rb	status	1.000000	12.000000	2.000000	12878
1535	receptor	expression	2.000000	44.000000	87.000000	12878
1536	sequence	present	1.000000	22.000000	1.000000	12878
1537	tcr-induced	protein	1.000000	1.000000	59.000000	12878
1538	therapeutic	strategies	1.000000	2.000000	1.000000	12878
1539	tnf	mrna	4.000000	14.000000	31.000000	12878
1540	transfection	experiments	1.000000	10.000000	6.000000	12878
1541	tyrosine	kinase	9.000000	28.000000	35.000000	12878
1542	b2	isoform	1.000000	2.000000	1.000000	12878
1543	binding	characteristics	1.000000	39.000000	1.000000	12878
1544	cell	antigen	2.000000	69.000000	8.000000	12878
1546	cytokine	genes	1.000000	11.000000	16.000000	12878
1547	cytokine	interleukin	1.000000	11.000000	7.000000	12878
1548	differential	effects	1.000000	7.000000	18.000000	12878
1549	egr-1	induction	1.000000	6.000000	42.000000	12878
1550	hel/	s	2.000000	2.000000	7.000000	12878
1551	higher	order	1.000000	2.000000	2.000000	12878
1555	neutrophil	adhesion	1.000000	1.000000	14.000000	12878
1558	nuclear	translocation	1.000000	29.000000	2.000000	12878
1559	peripheral	adaptation	1.000000	9.000000	1.000000	12878
1560	response	factor	2.000000	22.000000	45.000000	12878
1561	transactivator	protein	1.000000	4.000000	59.000000	12878
1562	17-bp	gas	1.000000	2.000000	3.000000	12878
1563	antigen-presenting	cells	1.000000	1.000000	152.000000	12878
1565	cd4	gene	1.000000	7.000000	96.000000	12878
1566	components	tyrosine	1.000000	1.000000	28.000000	12878
1567	epor	gene	1.000000	3.000000	96.000000	12878
1569	general	transcription	2.000000	2.000000	80.000000	12878
1570	gos19.1	promoter	1.000000	1.000000	63.000000	12878
1572	human	cells	3.000000	72.000000	152.000000	12878
1574	human	th2-type	1.000000	72.000000	1.000000	12878
1575	kinases	p56lck	1.000000	10.000000	1.000000	12878
1576	long	terminal	1.000000	1.000000	1.000000	12878
1579	ras	activation	1.000000	1.000000	72.000000	12878
1581	regulatory	proteins	1.000000	7.000000	36.000000	12878
1582	ri	transcript	1.000000	4.000000	2.000000	12878
1583	ri	transcription	1.000000	4.000000	80.000000	12878
1584	roi	formation	1.000000	1.000000	8.000000	12878
1585	sp1	motifs	1.000000	15.000000	4.000000	12878
1594	ck-1	element	1.000000	1.000000	16.000000	12878
1596	il-2	share	1.000000	26.000000	1.000000	12878
1597	il-2-mediated	t	1.000000	1.000000	76.000000	12878
1600	nm23-h2	protein	1.000000	3.000000	59.000000	12878
1601	surface	molecule	1.000000	10.000000	1.000000	12878
1604	various	differentiation	1.000000	13.000000	25.000000	12878
1606	cell	killing	1.000000	69.000000	1.000000	12878
1607	chronic	phase	1.000000	3.000000	6.000000	12878
1608	differential	modification	1.000000	7.000000	1.000000	12878
1609	equivalent	levels	1.000000	1.000000	27.000000	12878
1610	genomic	sequence	1.000000	1.000000	22.000000	12878
1611	higher	rate	1.000000	2.000000	7.000000	12878
1613	ifn-gamma	gene	1.000000	32.000000	96.000000	12878
1614	igg	fc	2.000000	2.000000	11.000000	12878
1615	ii	genes	1.000000	16.000000	16.000000	12878
1616	ii	mhc	1.000000	16.000000	7.000000	12878
1617	intense	tyrosine	1.000000	3.000000	28.000000	12878
1620	last	site	1.000000	1.000000	39.000000	12878
1623	natural	history	1.000000	3.000000	1.000000	12878
1624	nonstatic	assays	1.000000	1.000000	11.000000	12878
1628	ric	gene	2.000000	5.000000	96.000000	12878
1630	t-cell	lines	1.000000	6.000000	13.000000	12878
1633	alpha-globin	promoter	6.000000	10.000000	63.000000	12878
1635	ap-1-like	complex	1.000000	1.000000	17.000000	12878
1636	apoptotic	peer	1.000000	3.000000	2.000000	12878
1637	chloramphenicol	acetyltransferase	1.000000	1.000000	1.000000	12878
1641	inert	quality	1.000000	1.000000	1.000000	12878
1642	lymphoma	cells	1.000000	2.000000	152.000000	12878
1643	platelet	factor	2.000000	3.000000	45.000000	12878
1644	primate	cell	1.000000	1.000000	69.000000	12878
1645	proteasome	inhibitor	1.000000	1.000000	9.000000	12878
1646	super-shift	analysis	1.000000	1.000000	12.000000	12878
1647	tnf-alpha-stimulated	cells	1.000000	1.000000	152.000000	12878
1648	transcription	factors	16.000000	80.000000	23.000000	12878
1649	transcriptional	activation	2.000000	23.000000	72.000000	12878
1652	abnormal	regulation	1.000000	1.000000	15.000000	12878
1653	adaptive	mechanisms	1.000000	1.000000	10.000000	12878
1654	deficient	b-cell	1.000000	2.000000	3.000000	12878
1656	epo	acts	1.000000	6.000000	3.000000	12878
1658	hiv-2	enhancer	4.000000	6.000000	16.000000	12878
1659	htlv-i-mediated	t	1.000000	1.000000	76.000000	12878
1661	ii	molecules	2.000000	16.000000	4.000000	12878
1662	janus	family	1.000000	1.000000	11.000000	12878
1663	mammary	gland	1.000000	1.000000	1.000000	12878
1665	nk3.3	cells	1.000000	2.000000	152.000000	12878
1667	phosphatase	pp2a	1.000000	6.000000	1.000000	12878
1673	stat4	expression	1.000000	1.000000	87.000000	12878
1674	transcriptional	activator	1.000000	23.000000	4.000000	12878
1676	various	jurkat	1.000000	13.000000	13.000000	12878
1679	-m2	proteins	1.000000	1.000000	36.000000	12878
1680	c-fos	induction	5.000000	17.000000	42.000000	12878
1682	distinct	cytokine	1.000000	17.000000	11.000000	12878
1683	enhanced	nf-kappa	1.000000	4.000000	44.000000	12878
1688	integrin	ligation	2.000000	3.000000	4.000000	12878
1692	promoter	fragments	1.000000	63.000000	1.000000	12878
1693	protein	complex	1.000000	59.000000	17.000000	12878
1694	proximal	promoter	3.000000	6.000000	63.000000	12878
1695	purine-rich	region	1.000000	3.000000	28.000000	12878
1696	recent	characterization	1.000000	3.000000	2.000000	12878
1699	alpha	b1/	1.000000	56.000000	1.000000	12878
1701	dp1	complex	1.000000	1.000000	17.000000	12878
1702	family	member	1.000000	11.000000	5.000000	12878
1703	full	promoter	1.000000	4.000000	63.000000	12878
1704	glucoc	orticoid	1.000000	1.000000	1.000000	12878
1706	human	bone	1.000000	72.000000	3.000000	12878
1709	interferon-gamma	activation	1.000000	4.000000	72.000000	12878
1715	proinflammatory	cytokines	1.000000	1.000000	10.000000	12878
1717	rb-defective	lines	2.000000	5.000000	13.000000	12878
1718	reactive	oxygen	2.000000	2.000000	2.000000	12878
1719	several	e2f	1.000000	11.000000	5.000000	12878
1720	several	elements	1.000000	11.000000	12.000000	12878
1721	simian	immunodeficiency	1.000000	1.000000	3.000000	12878
1722	stat	proteins	7.000000	13.000000	36.000000	12878
1724	syk	tyrosine	2.000000	5.000000	28.000000	12878
1725	complete	t	1.000000	1.000000	76.000000	12878
1729	factor	iv	2.000000	45.000000	2.000000	12878
1730	inhibitory	action	1.000000	8.000000	4.000000	12878
1731	luf	syndrome	1.000000	1.000000	2.000000	12878
1732	message	levels	1.000000	3.000000	27.000000	12878
1733	mmol/	l	1.000000	1.000000	1.000000	12878
1734	order	nf-atp	1.000000	2.000000	2.000000	12878
1735	potential	inhibition	1.000000	3.000000	10.000000	12878
1736	run-on	assay	1.000000	3.000000	6.000000	12878
1740	cdna	library	1.000000	3.000000	1.000000	12878
1742	different	cd4	2.000000	16.000000	4.000000	12878
1743	e1a	expression	2.000000	6.000000	87.000000	12878
1744	early	stages	1.000000	5.000000	2.000000	12878
1746	family	tyrosine	1.000000	11.000000	28.000000	12878
1750	hormone	erythropoietin	1.000000	1.000000	4.000000	12878
1754	ic	gene	1.000000	1.000000	96.000000	12878
1756	kinase	expression	4.000000	35.000000	87.000000	12878
1757	large	diffusion	1.000000	4.000000	1.000000	12878
1758	mobility	shift	7.000000	8.000000	8.000000	12878
1762	similar	activities	1.000000	9.000000	3.000000	12878
1763	synthesis-independent	appearance	1.000000	1.000000	4.000000	12878
1764	tata	sequence	1.000000	3.000000	22.000000	12878
1765	5&apos;-flanking	region	1.000000	1.000000	28.000000	12878
1769	e-selectin	expression	2.000000	9.000000	87.000000	12878
1770	human	gm-csf	2.000000	72.000000	26.000000	12878
1771	likely	dp-i	1.000000	3.000000	1.000000	12878
1772	line	jurkat	1.000000	19.000000	13.000000	12878
1773	mouse	granulocyte/	1.000000	8.000000	1.000000	12878
1774	receptor	number	1.000000	44.000000	10.000000	12878
1775	signal-transduction	pathway	1.000000	1.000000	13.000000	12878
1776	stat	protein	3.000000	13.000000	59.000000	12878
1777	t	cells-binding	1.000000	76.000000	1.000000	12878
1782	cd4	epitopes	2.000000	4.000000	3.000000	12878
1783	cgmp	analogues	1.000000	1.000000	1.000000	12878
1786	differentiation	inducers	1.000000	25.000000	3.000000	12878
1787	downstream	site	1.000000	3.000000	39.000000	12878
1789	histidine	residue	1.000000	1.000000	1.000000	12878
1790	hiv-1	enhancer	1.000000	4.000000	16.000000	12878
1791	ii	expression	2.000000	16.000000	87.000000	12878
1793	life	cycle	1.000000	1.000000	2.000000	12878
1794	mhc	antigen	1.000000	7.000000	8.000000	12878
1795	mhc	genes	1.000000	7.000000	16.000000	12878
1797	nuclear	factor-kappa	5.000000	29.000000	5.000000	12878
1798	okadaic	acid	3.000000	5.000000	6.000000	12878
1800	single	gata-binding	1.000000	7.000000	1.000000	12878
1803	transcription	proteins	1.000000	80.000000	36.000000	12878
1805	ck-1/	cd28re	2.000000	2.000000	4.000000	12878
1806	consensus	ah	1.000000	5.000000	4.000000	12878
1808	diminished	gr	1.000000	1.000000	4.000000	12878
1809	duffy	gene	1.000000	4.000000	96.000000	12878
1810	er	mrna	2.000000	6.000000	31.000000	12878
1811	erythroid-specific	repression	1.000000	2.000000	4.000000	12878
1812	granulocyte/	macrophage-colony	1.000000	1.000000	1.000000	12878
1813	human	t	8.000000	72.000000	76.000000	12878
1814	mrna	expression	1.000000	31.000000	87.000000	12878
1817	several	cytokines	1.000000	11.000000	10.000000	12878
1818	subsequent	degradation	2.000000	4.000000	7.000000	12878
1821	transcriptional	start	2.000000	23.000000	4.000000	12878
1829	il-2	mrna	1.000000	24.000000	31.000000	12878
1830	il-2-independent	growth	1.000000	1.000000	7.000000	12878
1831	marginal	amounts	1.000000	2.000000	4.000000	12878
1832	mature	cell	1.000000	1.000000	69.000000	12878
1833	oxygen	production	1.000000	2.000000	9.000000	12878
1835	stable	e1a	1.000000	3.000000	6.000000	12878
1838	therapeutical	levels	1.000000	1.000000	27.000000	12878
1839	tnf	production	1.000000	14.000000	9.000000	12878
1840	tpa	treatment	1.000000	2.000000	10.000000	12878
1841	transcriptional	inhibitors	1.000000	23.000000	11.000000	12878
1843	various	v-atpase	1.000000	13.000000	3.000000	12878
1845	vital	importance	1.000000	1.000000	2.000000	12878
1846	vitro	translation	1.000000	10.000000	1.000000	12878
1847	wp	promoter	1.000000	1.000000	63.000000	12878
1848	cleo	element	1.000000	3.000000	16.000000	12878
1849	mitogenic	stimulation	1.000000	1.000000	21.000000	12878
1850	bacterial	endotoxin	1.000000	2.000000	1.000000	12878
1852	biochemical	response	1.000000	4.000000	22.000000	12878
1853	blast-crisis	cdna	1.000000	1.000000	3.000000	12878
1854	cd19	gene	1.000000	1.000000	96.000000	12878
1856	common	stat	1.000000	3.000000	13.000000	12878
1857	cooh-terminal	portion	1.000000	1.000000	1.000000	12878
1858	crisis	phase	1.000000	2.000000	6.000000	12878
1859	erythroleukemia	cell	1.000000	1.000000	69.000000	12878
1860	fc	gamma	9.000000	11.000000	11.000000	12878
1861	gata-binding	site	1.000000	1.000000	39.000000	12878
1862	il-2	receptor	1.000000	26.000000	44.000000	12878
1864	lineage	commitment	3.000000	3.000000	4.000000	12878
1867	nonradioactive	assay	1.000000	2.000000	6.000000	12878
1868	novel	model	1.000000	10.000000	6.000000	12878
1869	nuclear	levels	1.000000	29.000000	27.000000	12878
1871	promoter-proximal	region	1.000000	1.000000	28.000000	12878
1872	protein	synthesis-independent	1.000000	59.000000	1.000000	12878
1874	significant	differences	1.000000	8.000000	4.000000	12878
1875	structural	motifs	1.000000	1.000000	4.000000	12878
1876	vivo	studies	1.000000	3.000000	10.000000	12878
1877	degradation	rate	1.000000	7.000000	7.000000	12878
1878	integrated	alpha-globin	1.000000	1.000000	10.000000	12878
1879	model	system	1.000000	6.000000	3.000000	12878
1880	murine	homolog	1.000000	3.000000	1.000000	12878
1881	real	effect	1.000000	1.000000	21.000000	12878
1882	signal	transducers	2.000000	8.000000	2.000000	12878
1883	soluble	cytokines	1.000000	1.000000	10.000000	12878
1884	subunit	promoter	1.000000	4.000000	63.000000	12878
1886	tnf-stimulated	huvecs	1.000000	1.000000	2.000000	12878
1888	vcam-1	transcription	1.000000	12.000000	80.000000	12878
1890	17-bp	sequence	1.000000	2.000000	22.000000	12878
1891	antigen/	chemokine	1.000000	1.000000	2.000000	12878
1892	b7	costimulation	1.000000	7.000000	5.000000	12878
1893	darc	gene	1.000000	2.000000	96.000000	12878
1894	distinct	transcription	1.000000	17.000000	80.000000	12878
1895	double-stranded	gire	1.000000	1.000000	4.000000	12878
1896	gata-1	activity	2.000000	11.000000	46.000000	12878
1897	gel	mobility	2.000000	3.000000	8.000000	12878
1898	granulocyte	colony-stimulating	1.000000	2.000000	7.000000	12878
1899	group	antigen	1.000000	4.000000	8.000000	12878
1902	human	interleukin-2	1.000000	72.000000	7.000000	12878
1903	human	monocytes	2.000000	72.000000	27.000000	12878
1904	important	role	4.000000	13.000000	15.000000	12878
1906	k562	cells	3.000000	5.000000	152.000000	12878
1907	line	nk3.3	1.000000	19.000000	1.000000	12878
1908	mip-1	alpha	3.000000	5.000000	56.000000	12878
1909	molecular	bases	1.000000	6.000000	1.000000	12878
1910	monocytic	cells	3.000000	7.000000	152.000000	12878
1911	nk	cell	1.000000	4.000000	69.000000	12878
1912	plasmodium	vivax	1.000000	1.000000	1.000000	12878
1914	tnf	stimulation	1.000000	14.000000	21.000000	12878
1915	transcription	activity	2.000000	80.000000	46.000000	12878
1918	common	control	1.000000	3.000000	14.000000	12878
1919	gene	expression	21.000000	96.000000	87.000000	12878
1920	gm-csf	promoter	6.000000	26.000000	63.000000	12878
1921	new	family	1.000000	7.000000	11.000000	12878
1922	a-gene	product	1.000000	1.000000	8.000000	12878
1923	cd28-mediated	activation	1.000000	1.000000	72.000000	12878
1924	coimmunoprecipitation	experiments	1.000000	1.000000	6.000000	12878
1925	double-labeled	probe	1.000000	1.000000	3.000000	12878
1926	epstein-barr	virus	2.000000	2.000000	9.000000	12878
1929	hel	cells	3.000000	4.000000	152.000000	12878
1932	luciferase	reporter	1.000000	2.000000	10.000000	12878
1934	t1/	2	1.000000	1.000000	8.000000	12878
1935	type	2	2.000000	8.000000	8.000000	12878
1939	a-treated	cells	1.000000	1.000000	152.000000	12878
1940	alpha	transcripts	1.000000	56.000000	2.000000	12878
1941	antimouse	alpha	1.000000	1.000000	56.000000	12878
1942	bcl-2	expression	1.000000	1.000000	87.000000	12878
1944	cell	adhesion	4.000000	69.000000	14.000000	12878
1946	colony-stimulating	factor	7.000000	7.000000	45.000000	12878
1950	factor	nf-kappa	3.000000	45.000000	44.000000	12878
1951	fresh	pbl	1.000000	1.000000	2.000000	12878
1952	high	degree	2.000000	11.000000	2.000000	12878
1954	ii	inducibility	2.000000	16.000000	4.000000	12878
1955	interleukin-2	receptor	1.000000	7.000000	44.000000	12878
1957	monocyte	adhesion	4.000000	6.000000	14.000000	12878
1959	nucleotide	exchange	1.000000	2.000000	1.000000	12878
1960	other	ccgccc	1.000000	9.000000	1.000000	12878
1961	possible	mechanism	1.000000	4.000000	9.000000	12878
1962	research	groups	1.000000	1.000000	1.000000	12878
1963	scl	gene	1.000000	2.000000	96.000000	12878
1965	vivo	survival	1.000000	3.000000	1.000000	12878
1969	ap-1	complex	1.000000	8.000000	17.000000	12878
1970	ca2+	activation	1.000000	4.000000	72.000000	12878
1971	ebna-1	gene	1.000000	1.000000	96.000000	12878
1973	ie2	gene	1.000000	2.000000	96.000000	12878
1974	integrin-mediated	tyrosine	2.000000	2.000000	28.000000	12878
1975	interleukin-2-dependent	transcription	1.000000	1.000000	80.000000	12878
1976	multiple	copies	1.000000	7.000000	1.000000	12878
1977	nonradioactive	quantification	1.000000	2.000000	2.000000	12878
1979	progenitor	cells	2.000000	2.000000	152.000000	12878
1980	protein	1	1.000000	59.000000	7.000000	12878
1981	reporter	gene	7.000000	10.000000	96.000000	12878
1982	significant	relatedness	1.000000	8.000000	1.000000	12878
1983	unknown	mechanism	2.000000	4.000000	9.000000	12878
1984	antiinflammatory	properties	1.000000	1.000000	2.000000	12878
1985	b2	subunit	1.000000	2.000000	4.000000	12878
1986	b95-8	cells	1.000000	4.000000	152.000000	12878
1987	blood	monocytes	1.000000	9.000000	27.000000	12878
1988	cd28	ligation	1.000000	4.000000	4.000000	12878
1989	cellular	composition	2.000000	8.000000	2.000000	12878
1990	conflicting	results	1.000000	1.000000	27.000000	12878
1991	fva	cell	1.000000	2.000000	69.000000	12878
1995	jurkat	j6	1.000000	13.000000	1.000000	12878
1996	lac-z	transfectants	1.000000	2.000000	3.000000	12878
2001	similar	manner	1.000000	9.000000	7.000000	12878
2004	tat	expression	1.000000	2.000000	87.000000	12878
2005	differential	activation	1.000000	7.000000	72.000000	12878
2006	enhancer	element	3.000000	16.000000	16.000000	12878
2007	er-mediated	repression	1.000000	1.000000	4.000000	12878
2008	etiological	agent	1.000000	1.000000	1.000000	12878
2013	kd	fractions	1.000000	1.000000	1.000000	12878
2014	line	thp-1	2.000000	19.000000	2.000000	12878
2015	mouse	nm23-m1	1.000000	8.000000	1.000000	12878
2018	potent	inducers	1.000000	4.000000	3.000000	12878
2022	type	ic	1.000000	8.000000	1.000000	12878
2023	various	cell	1.000000	13.000000	69.000000	12878
2027	binding	protein	2.000000	39.000000	59.000000	12878
2030	different	protein	1.000000	16.000000	59.000000	12878
2032	fy@star@b	alleles	1.000000	2.000000	1.000000	12878
2033	hiv	pathogenesis	1.000000	8.000000	1.000000	12878
2035	mutant	nm23-h2his	1.000000	1.000000	1.000000	12878
2036	t-cell-expressed	cytokines	1.000000	2.000000	10.000000	12878
2037	transcriptional	response	1.000000	23.000000	22.000000	12878
2038	action	law	1.000000	4.000000	1.000000	12878
2040	b-cell	lines	2.000000	3.000000	13.000000	12878
2041	basic-helix-loop-helix	motif	1.000000	1.000000	7.000000	12878
2042	biologic	markers	1.000000	1.000000	5.000000	12878
2043	body	temperature	1.000000	1.000000	1.000000	12878
2045	different	genes	1.000000	16.000000	16.000000	12878
2047	e-selectin	upregulation	1.000000	9.000000	1.000000	12878
2048	gm-csf	gene	2.000000	26.000000	96.000000	12878
2052	jak2	kinase	1.000000	4.000000	35.000000	12878
2053	linear	configuration	1.000000	2.000000	1.000000	12878
2054	metastasis	regulation	1.000000	3.000000	15.000000	12878
2058	runoff	experiments	1.000000	1.000000	6.000000	12878
2059	serine/	threonine	1.000000	1.000000	1.000000	12878
2061	transcriptional	rate	1.000000	23.000000	7.000000	12878
2063	viral	gene	1.000000	4.000000	96.000000	12878
2064	bind	hematopoietin	1.000000	9.000000	2.000000	12878
2065	cancer	therapy	1.000000	3.000000	1.000000	12878
2067	cd3	zeta	1.000000	1.000000	1.000000	12878
2068	common	dna	1.000000	3.000000	19.000000	12878
2069	differential	manner	1.000000	7.000000	7.000000	12878
2070	g-protein-coupled	receptor	1.000000	1.000000	44.000000	12878
2071	gene	transcription	7.000000	96.000000	80.000000	12878
2072	gr	expression	1.000000	4.000000	87.000000	12878
2075	important	aspect	1.000000	13.000000	1.000000	12878
2078	mrna	stability	2.000000	31.000000	3.000000	12878
2079	myeloid	differentiation	1.000000	7.000000	25.000000	12878
2081	tal1	expression	1.000000	6.000000	87.000000	12878
2082	transcriptional	repressor	1.000000	23.000000	2.000000	12878
2083	tyrosine-phosphorylated	motifs	1.000000	1.000000	4.000000	12878
2084	umbilical	vein	1.000000	1.000000	2.000000	12878
2087	3t3	cells	1.000000	1.000000	152.000000	12878
2088	activation	domain	1.000000	72.000000	6.000000	12878
2089	adjacent	kappa	1.000000	2.000000	22.000000	12878
2090	cd28	cell	1.000000	4.000000	69.000000	12878
2091	clinical	data	1.000000	2.000000	10.000000	12878
2092	different	role	1.000000	16.000000	15.000000	12878
2093	endothelial	expression	2.000000	14.000000	87.000000	12878
2094	gata	motif	1.000000	1.000000	7.000000	12878
2097	inflammatory	responses	1.000000	3.000000	2.000000	12878
2098	intact	promoter	1.000000	2.000000	63.000000	12878
2099	lps	response	2.000000	12.000000	22.000000	12878
2100	mouse	gene	1.000000	8.000000	96.000000	12878
2101	p95vav	synergizes	1.000000	12.000000	1.000000	12878
2102	present	findings	1.000000	6.000000	4.000000	12878
2104	protooncogene	c-fos	1.000000	1.000000	17.000000	12878
2105	rbpi21	acts	1.000000	2.000000	3.000000	12878
2107	u937	monocytes	1.000000	13.000000	27.000000	12878
2109	ap-1	activity	2.000000	8.000000	46.000000	12878
2110	consensus	nf-kappa	1.000000	5.000000	44.000000	12878
2112	e1a	proteins	1.000000	6.000000	36.000000	12878
2113	endothelial	cells	6.000000	14.000000	152.000000	12878
2114	granulocyte-macrophage	colony-stimulating	6.000000	7.000000	7.000000	12878
2115	human	jurkat	1.000000	72.000000	13.000000	12878
2117	il-1	responsiveness	1.000000	6.000000	8.000000	12878
2118	immune	response	2.000000	4.000000	22.000000	12878
2120	marrow	cultures	1.000000	1.000000	1.000000	12878
2123	nfat-1-mediated	gene	1.000000	3.000000	96.000000	12878
2126	pebp2	site-binding	1.000000	6.000000	1.000000	12878
2128	rat	tissues	1.000000	2.000000	4.000000	12878
2130	signal-induced	phosphorylation	2.000000	2.000000	37.000000	12878
2132	trophoblast	cells	1.000000	1.000000	152.000000	12878
2133	virus	type	3.000000	9.000000	8.000000	12878
2135	monocytes	results	1.000000	27.000000	27.000000	12878
2137	clinical	disease	1.000000	2.000000	1.000000	12878
2139	enhancer/	promoter	1.000000	1.000000	63.000000	12878
2141	gata-1	mrna	1.000000	11.000000	31.000000	12878
2144	hypothetical	model	1.000000	1.000000	6.000000	12878
2146	interleukin	2	1.000000	7.000000	8.000000	12878
2147	n-terminal	peptides	1.000000	4.000000	2.000000	12878
2150	slow	rate	1.000000	1.000000	7.000000	12878
2152	tal1	protein	1.000000	6.000000	59.000000	12878
2153	varied	effects	1.000000	1.000000	18.000000	12878
2159	granulocyte-macrophage	csf	1.000000	7.000000	1.000000	12878
2160	human	cd19	1.000000	72.000000	1.000000	12878
2164	inhibitory	activity	5.000000	8.000000	46.000000	12878
2167	nucleotide	-46	1.000000	2.000000	1.000000	12878
2168	p65	subunits	1.000000	1.000000	3.000000	12878
2169	pleckstrin	homology	1.000000	1.000000	4.000000	12878
2172	single	transcription	1.000000	7.000000	80.000000	12878
2174	threonine	phosphatases	1.000000	1.000000	1.000000	12878
2175	transcript	levels	1.000000	2.000000	27.000000	12878
2176	tumor	cell	2.000000	10.000000	69.000000	12878
2178	assay	result	1.000000	6.000000	2.000000	12878
2179	cd4-cd8-	t	1.000000	3.000000	76.000000	12878
2185	full	function	1.000000	4.000000	10.000000	12878
2187	high	levels	3.000000	11.000000	27.000000	12878
2188	hiv-2	functions	1.000000	6.000000	5.000000	12878
2191	human	osteosarcoma	1.000000	72.000000	1.000000	12878
2193	integer	numbers	1.000000	1.000000	1.000000	12878
2195	lymphoma	model	1.000000	2.000000	6.000000	12878
2197	new	protein	1.000000	7.000000	59.000000	12878
2198	opposite	situation	1.000000	1.000000	2.000000	12878
2199	receptor	affinity	1.000000	44.000000	8.000000	12878
2200	substantial	amounts	1.000000	1.000000	4.000000	12878
2202	transcriptional	complex	2.000000	23.000000	17.000000	12878
2204	calcium-mediated	activation	1.000000	1.000000	72.000000	12878
2205	enzyme	immunoassays	1.000000	5.000000	1.000000	12878
2207	high	level	3.000000	11.000000	9.000000	12878
2209	human	cytomegalovirus	2.000000	72.000000	2.000000	12878
2210	ie2	transactivation	1.000000	2.000000	2.000000	12878
2211	initiator-like	sequence	1.000000	1.000000	22.000000	12878
2213	new	world	2.000000	7.000000	2.000000	12878
2214	nfat	activation	2.000000	6.000000	72.000000	12878
2215	p2	promoter	1.000000	1.000000	63.000000	12878
2216	pebp2	site	1.000000	6.000000	39.000000	12878
2218	significant	finding	1.000000	8.000000	2.000000	12878
2222	adhesion	molecules	2.000000	14.000000	4.000000	12878
2223	antigenic	peptide	1.000000	1.000000	2.000000	12878
2224	cell	death	1.000000	69.000000	1.000000	12878
2226	cytokine	gene	3.000000	3.000000	96.000000	12878
2227	differentiation	induction	1.000000	25.000000	42.000000	12878
2228	e-selectin	surface	1.000000	9.000000	10.000000	12878
2230	functional	relationship	1.000000	9.000000	3.000000	12878
2231	fundamental	differences	1.000000	2.000000	4.000000	12878
2235	il-2	respond	1.000000	24.000000	1.000000	12878
2237	initial	phase	1.000000	1.000000	6.000000	12878
2238	lps-induced	e-selectin	1.000000	3.000000	9.000000	12878
2242	rb	expression	1.000000	12.000000	87.000000	12878
2243	basal	levels	1.000000	4.000000	27.000000	12878
2246	decreases	transcription	1.000000	1.000000	80.000000	12878
2247	er	bind	1.000000	6.000000	9.000000	12878
2248	factor	sp1	1.000000	45.000000	1.000000	12878
2249	first	description	1.000000	4.000000	1.000000	12878
2250	gene	constructs	1.000000	96.000000	3.000000	12878
2253	ick-1	site	1.000000	4.000000	39.000000	12878
2254	il-2-inducible	enhancer	1.000000	3.000000	16.000000	12878
2255	il-3	gene	1.000000	1.000000	96.000000	12878
2258	lymphoblastoid	cells	1.000000	1.000000	152.000000	12878
2259	monocytic	differentiation	1.000000	7.000000	25.000000	12878
2260	other	cell	1.000000	9.000000	69.000000	12878
2261	phosphatase	inhibitors	3.000000	6.000000	11.000000	12878
2262	present	experiment	1.000000	6.000000	1.000000	12878
2264	sephacryl	g-200	1.000000	1.000000	1.000000	12878
2266	surface	enzyme	1.000000	10.000000	5.000000	12878
2268	apoptotic	cell	1.000000	3.000000	69.000000	12878
2272	expression	constructs	1.000000	87.000000	3.000000	12878
2273	extracellular	signals	1.000000	1.000000	17.000000	12878
2274	factor	gene	1.000000	45.000000	96.000000	12878
2275	flow	cytometry	1.000000	1.000000	1.000000	12878
2279	maz	transcription	1.000000	2.000000	80.000000	12878
2280	mouse	homologue	1.000000	8.000000	1.000000	12878
2281	necrosis	factor-alpha	1.000000	4.000000	1.000000	12878
2282	nuclear	run-on	2.000000	29.000000	3.000000	12878
2283	promoter-luciferase	reporter	1.000000	1.000000	10.000000	12878
2284	shift	experiments	1.000000	8.000000	6.000000	12878
2286	t	helper	1.000000	76.000000	1.000000	12878
2288	adhesion	molecule-1	4.000000	14.000000	4.000000	12878
2292	blast	crisis	1.000000	1.000000	2.000000	12878
2293	diverse	cell	1.000000	1.000000	69.000000	12878
2294	dna	replication	1.000000	19.000000	1.000000	12878
2295	gene	products	1.000000	96.000000	4.000000	12878
2297	ifn-gamma	treatment	1.000000	32.000000	10.000000	12878
2298	il-2	transcription	2.000000	24.000000	80.000000	12878
2299	interleukin	12	2.000000	7.000000	3.000000	12878
2300	jurkat	mutants	1.000000	13.000000	2.000000	12878
2301	luciferase	expression	1.000000	2.000000	87.000000	12878
2303	phosphorylate	stat	1.000000	1.000000	13.000000	12878
2304	potential	mechanisms	1.000000	3.000000	10.000000	12878
2310	alpha	mrna	1.000000	56.000000	31.000000	12878
2314	egr-1	gene	1.000000	6.000000	96.000000	12878
2316	kinase	activity	3.000000	35.000000	46.000000	12878
2317	ovulation	markers	1.000000	6.000000	5.000000	12878
2318	phorbol	esters	1.000000	2.000000	1.000000	12878
2319	rb-defective	tumor	2.000000	5.000000	10.000000	12878
2320	same	dna	1.000000	7.000000	19.000000	12878
2321	same	range	1.000000	7.000000	1.000000	12878
2323	unprimed	cells	3.000000	3.000000	152.000000	12878
2324	adenovirus	infection	1.000000	2.000000	13.000000	12878
2328	cell	extract	1.000000	69.000000	1.000000	12878
2329	complex	class	1.000000	2.000000	18.000000	12878
2330	control	il-2	1.000000	14.000000	26.000000	12878
2331	duffy-negative	blacks	1.000000	3.000000	1.000000	12878
2332	functional	criteria	1.000000	9.000000	2.000000	12878
2334	hiv	ltr	1.000000	8.000000	4.000000	12878
2336	inhibitors	genistein	1.000000	11.000000	3.000000	12878
2337	intracellular	substrates	1.000000	4.000000	1.000000	12878
2339	mrna	induction	3.000000	31.000000	42.000000	12878
2340	nm23	proteins	4.000000	10.000000	36.000000	12878
2342	t-cell	antigen	1.000000	6.000000	8.000000	12878
2344	-c-c	family	1.000000	1.000000	11.000000	12878
2345	alpha	degradation	1.000000	56.000000	7.000000	12878
2348	cell	carcinomas	2.000000	69.000000	2.000000	12878
2350	gas-binding	proteins	1.000000	1.000000	36.000000	12878
2351	hematopoietic	cell	1.000000	8.000000	69.000000	12878
2354	ifn-gamma	responsiveness	1.000000	32.000000	8.000000	12878
2356	kinase	syk	1.000000	35.000000	5.000000	12878
2359	protein	heterodimers	1.000000	59.000000	2.000000	12878
2360	repressor	raz	1.000000	2.000000	2.000000	12878
2361	segment	functions	1.000000	2.000000	5.000000	12878
2362	site	result	1.000000	39.000000	2.000000	12878
2363	specific	band	1.000000	10.000000	3.000000	12878
2364	suppressor	genes	1.000000	4.000000	16.000000	12878
2365	transcription	machinery	1.000000	80.000000	1.000000	12878
2367	vcam-1	mrna	1.000000	12.000000	31.000000	12878
2370	cap	site	1.000000	1.000000	39.000000	12878
2371	cd4+	t	5.000000	5.000000	76.000000	12878
2372	cell	leukemia	1.000000	69.000000	7.000000	12878
2375	class	i	2.000000	18.000000	24.000000	12878
2376	comparable	enhancer	1.000000	2.000000	16.000000	12878
2378	gas	homology	1.000000	3.000000	4.000000	12878
2382	il-2	promoter	2.000000	24.000000	63.000000	12878
2386	rat	thymus	1.000000	2.000000	1.000000	12878
2387	segment	1.3	1.000000	2.000000	1.000000	12878
2388	single	cytokine	1.000000	7.000000	11.000000	12878
2390	tissue-specific	expression	1.000000	1.000000	87.000000	12878
2395	electrophoretic	mobility	4.000000	5.000000	8.000000	12878
2398	ii	proteins	1.000000	16.000000	36.000000	12878
2400	lfa-3triple	transfectant	1.000000	1.000000	1.000000	12878
2401	m1	cells	2.000000	2.000000	152.000000	12878
2404	normal	hematopoiesis	1.000000	9.000000	2.000000	12878
2405	p50	nf-kappa	1.000000	2.000000	44.000000	12878
2408	second	phase	1.000000	5.000000	6.000000	12878
2410	wide	variety	1.000000	1.000000	2.000000	12878
2411	acid	residues	1.000000	6.000000	2.000000	12878
2412	aml1	gene	1.000000	2.000000	96.000000	12878
2416	fc	receptor	2.000000	11.000000	44.000000	12878
2417	free	calcium	1.000000	1.000000	13.000000	12878
2418	hematopoietic	cells	2.000000	8.000000	152.000000	12878
2420	il-12	induction	1.000000	4.000000	42.000000	12878
2421	inhibitor	i	1.000000	9.000000	24.000000	12878
2424	myeloid	cells	2.000000	7.000000	152.000000	12878
2425	specific	bands	1.000000	10.000000	1.000000	12878
2427	adult	t	1.000000	1.000000	76.000000	12878
2429	consensus	sequence	3.000000	5.000000	22.000000	12878
2430	crisis	transition	1.000000	2.000000	2.000000	12878
2431	enhancer-dependent	effect	1.000000	1.000000	21.000000	12878
2432	ets	consensus	1.000000	1.000000	5.000000	12878
2433	granulocytic	differentiation	2.000000	2.000000	25.000000	12878
2435	i	kappa	18.000000	24.000000	22.000000	12878
2439	obvious	regulation	1.000000	2.000000	15.000000	12878
2441	pebp2	isoforms	1.000000	6.000000	1.000000	12878
2442	receptor	type	2.000000	44.000000	8.000000	12878
2443	rgd	domain	1.000000	1.000000	6.000000	12878
2444	s	cells	1.000000	7.000000	152.000000	12878
2445	tcr	signals	3.000000	16.000000	17.000000	12878
2446	tinur	binds	1.000000	4.000000	2.000000	12878
2447	v-atpase	subunits	1.000000	3.000000	3.000000	12878
2451	apparent	dissociation	1.000000	2.000000	1.000000	12878
2452	binding	site	6.000000	39.000000	39.000000	12878
2453	biophysical	ones	1.000000	1.000000	1.000000	12878
2454	cd28-responsive	complex	1.000000	1.000000	17.000000	12878
2457	cutaneous	carcinogenesis	1.000000	1.000000	1.000000	12878
2459	hiv	transcription	1.000000	8.000000	80.000000	12878
2462	molecular	lesion	1.000000	6.000000	1.000000	12878
2463	normal	lymphocytes	1.000000	9.000000	14.000000	12878
2465	repair	enzyme	2.000000	3.000000	5.000000	12878
2466	ric	promoter	1.000000	5.000000	63.000000	12878
2467	significant	effect	1.000000	8.000000	21.000000	12878
2468	similar	inhibition	1.000000	9.000000	10.000000	12878
2469	single	exon	1.000000	7.000000	3.000000	12878
2470	tyrosine	kinases	4.000000	28.000000	10.000000	12878
2471	c-rich	region	3.000000	5.000000	28.000000	12878
2472	cd4	coreceptor	2.000000	7.000000	2.000000	12878
2473	cell-specific	factors	1.000000	5.000000	23.000000	12878
2474	fy@star@b	allele	1.000000	2.000000	1.000000	12878
2476	htlv-i-associated	myelopathy	1.000000	1.000000	1.000000	12878
2479	immunoregulatory	protein	1.000000	2.000000	59.000000	12878
2480	inducible	expression	1.000000	7.000000	87.000000	12878
2481	inositol	phosphates	1.000000	1.000000	1.000000	12878
2484	non-erythroid	cells	2.000000	2.000000	152.000000	12878
2485	stat	family	1.000000	13.000000	11.000000	12878
2486	t-cell-expressed	cytokine	1.000000	2.000000	11.000000	12878
2487	transfection	assays	4.000000	10.000000	11.000000	12878
2488	b-cell	mutants	1.000000	3.000000	2.000000	12878
2490	beta	genes	1.000000	4.000000	16.000000	12878
2491	c-fos	control	2.000000	17.000000	14.000000	12878
2495	e1a	transfection	1.000000	6.000000	10.000000	12878
2497	erythroid	transcription	3.000000	24.000000	80.000000	12878
2498	hematopoietic	stem	1.000000	8.000000	3.000000	12878
2499	high-dose	estrogen	1.000000	1.000000	6.000000	12878
2502	human	lymphocytes	2.000000	72.000000	14.000000	12878
2503	immunologic	barrier	1.000000	1.000000	1.000000	12878
2504	lesser	extent	1.000000	1.000000	1.000000	12878
2505	nuclear	proteins	2.000000	29.000000	36.000000	12878
2506	plasma	cortisol	2.000000	2.000000	3.000000	12878
2508	retinoblastoma	susceptibility	1.000000	3.000000	5.000000	12878
2509	specific	mrna	1.000000	10.000000	31.000000	12878
2510	suppressor	protein	1.000000	4.000000	59.000000	12878
2511	transfection	assay	1.000000	10.000000	6.000000	12878
2513	various	functions	1.000000	13.000000	5.000000	12878
2516	acid	augments	1.000000	3.000000	1.000000	12878
2518	basal	level	1.000000	4.000000	9.000000	12878
2519	c-myc	gene	1.000000	1.000000	96.000000	12878
2522	er	gene	1.000000	5.000000	96.000000	12878
2524	hiv-1	gp120	1.000000	4.000000	1.000000	12878
2525	human	epor	1.000000	72.000000	3.000000	12878
2528	intracellular	formation	1.000000	4.000000	8.000000	12878
2529	jak	kinases	3.000000	4.000000	10.000000	12878
2530	ligand-dependent	repression	1.000000	3.000000	4.000000	12878
2532	maximal	increase	1.000000	1.000000	6.000000	12878
2533	new	gene	1.000000	7.000000	96.000000	12878
2534	rb-defective	cells	1.000000	5.000000	152.000000	12878
2535	receptor	alpha	2.000000	44.000000	56.000000	12878
2536	sp1	phosphorylation	2.000000	15.000000	37.000000	12878
2538	transient	transfections	1.000000	5.000000	1.000000	12878
2539	vcam-1	expression	2.000000	12.000000	87.000000	12878
2542	endothelial	monolayers	1.000000	14.000000	1.000000	12878
2543	erythropoietin	receptor	1.000000	4.000000	44.000000	12878
2544	gene	regulation	1.000000	96.000000	15.000000	12878
2545	hiv-2	display	1.000000	6.000000	1.000000	12878
2548	lymphocyte	reaction	1.000000	6.000000	1.000000	12878
2550	natural	killer	2.000000	3.000000	2.000000	12878
2554	pokeweed	mitogen	2.000000	2.000000	2.000000	12878
2556	transient	transfection	3.000000	5.000000	10.000000	12878
2557	virus-induced	erythroblasts	1.000000	1.000000	2.000000	12878
2558	anemia-inducing	strain	1.000000	1.000000	1.000000	12878
2559	cis-acting	elements	3.000000	4.000000	12.000000	12878
2560	cytoplasmic	tyrosine	1.000000	6.000000	28.000000	12878
2562	g-200	ultrafiltration	1.000000	1.000000	1.000000	12878
2563	gene	product	7.000000	96.000000	8.000000	12878
2564	gire	sequence	1.000000	4.000000	22.000000	12878
2566	gos19	promoter	1.000000	1.000000	63.000000	12878
2567	host	cell	1.000000	3.000000	69.000000	12878
2568	htlv-i-infected	cord	1.000000	2.000000	1.000000	12878
2573	orphan	receptor	1.000000	1.000000	44.000000	12878
2574	single	kappa	1.000000	7.000000	22.000000	12878
2576	transcription	initiation	3.000000	80.000000	3.000000	12878
2577	transfection	data	1.000000	10.000000	10.000000	12878
2579	type	ii	1.000000	8.000000	16.000000	12878
2580	%	decrease	1.000000	9.000000	2.000000	12878
2581	alpha	gene	5.000000	56.000000	96.000000	12878
2582	cat	reporter	1.000000	2.000000	10.000000	12878
2583	control	transcription	1.000000	14.000000	80.000000	12878
2584	cyclosporin	treatment	1.000000	2.000000	10.000000	12878
2585	enzyme	activity	2.000000	5.000000	46.000000	12878
2588	receptor	gene	3.000000	44.000000	96.000000	12878
2589	sequence	analysis	1.000000	22.000000	12.000000	12878
2590	sp1	proteins	1.000000	15.000000	36.000000	12878
2591	transcription	control	1.000000	80.000000	14.000000	12878
2593	cd28re	region	1.000000	4.000000	28.000000	12878
2594	cells	il-10	1.000000	152.000000	4.000000	12878
2596	cord	blood	1.000000	1.000000	9.000000	12878
2598	human	lymphocyte	1.000000	72.000000	6.000000	12878
2600	immunohistochemical	study	1.000000	1.000000	3.000000	12878
2601	inverted	repeats	1.000000	1.000000	1.000000	12878
2602	molecular	events	1.000000	6.000000	4.000000	12878
2603	nuclear	protein	2.000000	29.000000	59.000000	12878
2604	other	hand	1.000000	9.000000	1.000000	12878
2606	stem	cells	2.000000	3.000000	152.000000	12878
2608	tnf	alpha	1.000000	14.000000	56.000000	12878
2609	transcription	activation	1.000000	80.000000	72.000000	12878
2610	ad-infected	targets	1.000000	1.000000	1.000000	12878
2611	ca2+	ionophore	3.000000	4.000000	7.000000	12878
2613	cortisol	concentrations	3.000000	3.000000	5.000000	12878
2615	glucocorticoid	receptor	12.000000	17.000000	44.000000	12878
2616	hamster	ovary	1.000000	1.000000	1.000000	12878
2617	im-9	cell	1.000000	2.000000	69.000000	12878
2619	lymphocyte	immunoglobulin	1.000000	6.000000	2.000000	12878
2620	negative	effect	1.000000	6.000000	21.000000	12878
2623	positions	-51	1.000000	1.000000	1.000000	12878
2624	regulatory	element	2.000000	7.000000	16.000000	12878
2625	second	cell	1.000000	5.000000	69.000000	12878
2626	serum	response	3.000000	3.000000	22.000000	12878
2627	start	site	4.000000	4.000000	39.000000	12878
2628	vivax	malaria	1.000000	1.000000	1.000000	12878
